<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Metab</journal-id><journal-id journal-id-type="iso-abbrev">Mol Metab</journal-id><journal-title-group><journal-title>Molecular Metabolism</journal-title></journal-title-group><issn pub-type="epub">2212-8778</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27408775</article-id><article-id pub-id-type="pmc">4921804</article-id><article-id pub-id-type="publisher-id">S2212-8778(16)30036-9</article-id><article-id pub-id-type="doi">10.1016/j.molmet.2016.05.004</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>AGPAT2 is essential for postnatal development and maintenance of white and brown adipose tissue</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cautivo</surname><given-names>Kelly M.</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Lizama</surname><given-names>Carlos O.</given-names></name><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Tapia</surname><given-names>Pablo J.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Agarwal</surname><given-names>Anil K.</given-names></name><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Garg</surname><given-names>Abhimanyu</given-names></name><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Horton</surname><given-names>Jay D.</given-names></name><email>jay.horton@utsouthwestern.edu</email><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref><xref rid="cor2" ref-type="corresp">&#x02217;&#x02217;</xref></contrib><contrib contrib-type="author"><name><surname>Cort&#x000e9;s</surname><given-names>V&#x000ed;ctor A.</given-names></name><email>vcortes@med.puc.cl</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Nutrition, Diabetes and Metabolism, School of Medicine, Pontificia Universidad Cat&#x000f3;lica de Chile, Santiago 8331150, Chile</aff><aff id="aff2"><label>2</label>Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA</aff><aff id="aff3"><label>3</label>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA</aff><aff id="aff4"><label>4</label>Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94158, USA</aff><aff id="aff5"><label>5</label>Division of Nutrition and Metabolic Diseases, Center for Human Nutrition, Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, TX 75390, USA</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. Department of Nutrition, Diabetes and Metabolism, School of Medicine, Pontificia Universidad Cat&#x000f3;lica de Chile, Av. Libertador Bernardo O'Higgins 340, Santiago 8331150, Chile. Tel.:&#x000a0;+56 2 23546389; fax:&#x000a0;+56 2 26338298.Department of Nutrition, Diabetes and MetabolismSchool of MedicinePontificia Universidad Cat&#x000f3;lica de ChileAv. Libertador Bernardo O'Higgins 340Santiago8331150Chile <email>vcortes@med.puc.cl</email></corresp><corresp id="cor2"><label>&#x02217;&#x02217;</label>Corresponding author. Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Tel.:&#x000a0;+1 214 648 3644; fax:&#x000a0;+1 214 648 6388.Department of Molecular GeneticsUniversity of Texas Southwestern Medical CenterDallasTX75390USA <email>jay.horton@utsouthwestern.edu</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>13</day><month>5</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>7</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>13</day><month>5</month><year>2016</year></pub-date><volume>5</volume><issue>7</issue><fpage>491</fpage><lpage>505</lpage><history><date date-type="received"><day>13</day><month>2</month><year>2016</year></date><date date-type="rev-recd"><day>29</day><month>4</month><year>2016</year></date><date date-type="accepted"><day>6</day><month>5</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 The Authors</copyright-statement><copyright-year>2016</copyright-year><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><sec><title>Objective</title><p>Characterize the cellular and molecular events responsible for lipodystrophy in AGPAT2 deficient mice.</p></sec><sec><title>Methods</title><p>Adipose tissue and differentiated MEF were assessed using light and electron microscopy, followed by protein (immunoblots) and mRNA analysis (qPCR). Phospholipid profiling was determined by electrospray ionization tandem mass spectrometry (ESI-MS/MS).</p></sec><sec><title>Results</title><p>In contrast to adult <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice, fetuses and newborn <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice have normal mass of white and brown adipose tissue. Loss of both the adipose tissue depots occurs during the first week of postnatal life as a consequence of adipocyte death and inflammatory infiltration of the adipose tissue. At the ultrastructural level, adipose tissue of newborn <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice is virtually devoid of caveolae and has abnormal mitochondria and lipid droplets. Autophagic structures are also abundant. Consistent with these findings, differentiated <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mouse embryonic fibroblasts (MEFs) also have impaired adipogenesis, characterized by a lower number of lipid-laden cells and ultrastructural abnormalities in lipid droplets, mitochondria and plasma membrane. Overexpression of PPAR&#x003b3;, the master regulator of adipogenesis, increased the number of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs that differentiated into adipocyte-like cells but did not prevent morphological abnormalities and cell death. Furthermore, differentiated <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> MEFs have abnormal phospholipid compositions with 3-fold increased levels of phosphatidic acid.</p></sec><sec><title>Conclusion</title><p>We conclude that lipodystrophy in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice results from postnatal cell death of adipose tissue in association with acute local inflammation. It is possible that AGPAT2 deficient adipocytes have an altered lipid filling or a reduced capacity to adapt the massive lipid availability associated with postnatal feeding.</p></sec></abstract><abstract abstract-type="graphical" id="abs0015"><title>Graphical abstract</title><fig id="undfig1" position="anchor"><graphic xlink:href="fx1"/></fig></abstract><abstract abstract-type="author-highlights" id="abs0020"><title>Highlights</title><p><list list-type="simple"><list-item id="u0010"><label>&#x02022;</label><p>Post weaning <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice are lipodystrophic.</p></list-item><list-item id="u0015"><label>&#x02022;</label><p>However, they are born with normal mass of white and brown adipose tissue.</p></list-item><list-item id="u0020"><label>&#x02022;</label><p>Adipose tissue in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice undergoes postnatal inflammatory cell death.</p></list-item><list-item id="u0025"><label>&#x02022;</label><p>Differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs recapitulate abnormalities of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> adipocytes.</p></list-item><list-item id="u0030"><label>&#x02022;</label><p>Abnormal phospholipid composition might underlies lipodystrophy in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice.</p></list-item></list></p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>AGPAT2</kwd><kwd>Adipose tissue</kwd><kwd>Adipogenesis</kwd><kwd>Phospholipid</kwd><kwd>Lipodystrophy</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p>Congenital generalized lipodystrophy (CGL, Berardinelli-Seip syndrome) is a rare autosomal recessive disorder characterized by a lack of adipose tissue (AT). Affected individuals are prone to metabolic complications including insulin resistance, diabetes mellitus, hepatic steatosis and hypertriglyceridemia <xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>.</p><p>Mutations in the <italic>AGPAT2</italic> gene, encoding 1-acylglycerol-3-phosphate O-acyltransferase 2, cause the most common form of CGL, designated CGL-1 <xref rid="bib3" ref-type="bibr">[3]</xref>. Patients with CGL-1 have total absence of metabolically active adipose tissue, which is present in most subcutaneous regions, intra-abdominal and intra-thoracic regions and bone marrow; mechanical adipose tissue, which is present in the palms, soles, scalp, peri-articular regions and orbits, is completely preserved <xref rid="bib4" ref-type="bibr">[4]</xref>. Similarly, mice lacking AGPAT2 (<italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup>mice) have complete loss of both white and brown adipose tissue and manifest severe insulin resistance and hyperglycemia <xref rid="bib5" ref-type="bibr">[5]</xref>, <xref rid="bib6" ref-type="bibr">[6]</xref>. The mechanisms underlying the loss of adipose tissue in <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice remain unknown.</p><p>AGPAT2 belongs to a family of enzymes catalyzing the <italic>sn</italic>-2 acylation of the glycerol-3-phosphate backbone. This reaction converts lysophosphatidic acid (LPA) to phosphatidic acid (PA) in the <italic>de novo</italic> glycerolipid synthesis pathway <xref rid="bib7" ref-type="bibr">[7]</xref>. In humans and mice, AGPAT2 is a &#x0223c;31&#x000a0;KDa protein with four predicted transmembrane domains <xref rid="bib8" ref-type="bibr">[8]</xref> and specificity for LPA and acyl-CoA substrates <xref rid="bib9" ref-type="bibr">[9]</xref>, <xref rid="bib10" ref-type="bibr">[10]</xref>. Epitope tagged AGPAT2 localizes to the endoplasmic reticulum (ER) of CHO cells and primary mouse hepatocytes <xref rid="bib10" ref-type="bibr">[10]</xref>.</p><p>Lipodystrophy can result from either insufficient generation of mature adipocytes, i.e. defective adipogenesis, or accelerated adipocytes loss, i.e., defective adipose maintenance. Previous work with cell lines <xref rid="bib11" ref-type="bibr">[11]</xref>, <xref rid="bib12" ref-type="bibr">[12]</xref> and muscle-derived multipotent cells isolated from subjects harboring AGPAT2 mutations <xref rid="bib12" ref-type="bibr">[12]</xref> has suggested that AGPAT2 is required for adipogenic differentiation; however, the roles of AGPAT2 for <italic>in&#x000a0;vivo</italic> adipose tissue dynamics is unknown.</p><p>Herein, we characterized morphological, ultrastructural, and molecular changes of AT from <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice and assessed adipogenic differentiation in <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mouse embryonic fibroblasts (MEFs).</p></sec><sec id="sec2"><label>2</label><title>Materials and methods</title><sec id="sec2.1"><label>2.1</label><title>Mice</title><p><italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice were generated as described previously <xref rid="bib5" ref-type="bibr">[5]</xref>. <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> and <italic>Agpat2</italic><sup>+/+</sup> mice were obtained by mating of <italic>Agpat2</italic><sup><italic>+/&#x02212;</italic></sup> mice. Genotyping was performed by the PCR protocol as described <xref rid="bib5" ref-type="bibr">[5]</xref>. Adult mice were fed chow ad libitum. All mouse procedures were reviewed and approved by the Institutional Animal Care and Use Committee at Pontificia Universidad Cat&#x000f3;lica de Chile and University of Texas Southwestern Medical Center (UTSW).</p></sec><sec id="sec2.2"><label>2.2</label><title>Mouse embryonic fibroblasts (MEFs)</title><p><italic>Agpat2</italic><sup><italic>+/&#x02212;</italic></sup> pregnant females (14.5&#x000a0;d.p.c.) were sacrificed by isoflurane overdose. The embryos were removed, washed with ice cold sterile PBS, and sacrificed by decapitation. Maternal tissues, placental membranes, and internal organs were removed, and carcasses were rinsed with PBS and manually minced. The resulting material was digested with 0.25% trypsin/1&#x000a0;mM EDTA for 3&#x000a0;h at 4&#x000a0;&#x000b0;C and centrifuged. Cells were resuspended in DMEM 4.5&#x000a0;g/L glucose, supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2&#x000a0;mM <sc>l</sc>-glutamine, 0.1&#x000a0;mM nonessential amino acids, 100&#x000a0;&#x003bc;g/ml penicillin/streptomycin, and 0.1&#x000a0;mM 2-&#x003b2;-mercaptoethanol and seeded onto 150&#x000a0;mm plastic dishes. Because of <italic>Agpat2</italic><sup><italic>+/&#x02212;</italic></sup> mice mating, the embyros are of all three genotypes: <italic>Agpat2</italic><sup><italic>+/+</italic></sup>; <italic>Agpat2</italic><sup><italic>+/&#x02212;</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup>. Genomic DNA was isolated from tail biopsies of each embryo and only those of <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> genotypes were further processed. Genotyping PCR conditions are similar as mentioned before <xref rid="bib5" ref-type="bibr">[5]</xref>. MEFs were cultured until 100% confluence and frozen in liquid nitrogen at passage 1. All the experiments were performed at passage 3.</p></sec><sec id="sec2.3"><label>2.3</label><title>MEFs adipogenic differentiation</title><p>4&#x000a0;&#x000d7;&#x000a0;10<sup>5</sup> MEFs/well were seeded on 12-well plates and cultured in DMEM 4.5&#x000a0;g/L glucose, supplemented with 10% heat-inactivated FBS, 2&#x000a0;mM <sc>l</sc>-glutamine, 0.1&#x000a0;mM nonessential amino acids, 100&#x000a0;&#x003bc;g/ml penicillin/streptomycin, and 0.1&#x000a0;mM 2-&#x003b2;-mercaptoethanol. Adipogenesis was induced 2 days after confluency with induction medium (standard medium plus 1&#x000a0;&#x003bc;M dexamethasone, 0.5&#x000a0;mM 3-isobutyl-1-methylxanthine (IBMX), 10&#x000a0;&#x003bc;g/ml insulin) for 3 days. After induction, MEFs were fed an adipogenic differentiation medium (standard medium plus 10&#x000a0;&#x003bc;g/ml insulin and 10&#x000a0;&#x003bc;M rosiglitazone) for 2 additional days and then cultured in adipogenic maintenance medium (standard medium supplemented with 10&#x000a0;&#x003bc;g/ml insulin).</p></sec><sec id="sec2.4"><label>2.4</label><title>Histology and immunofluorescence</title><p>E18.5 embryos and newborn mice were euthanized by CO<sub>2</sub> anesthesia following cervical decapitation. Immediately, they were rinsed with 1X PBS and fixed overnight in 4% PFA/PBS and then transferred into 30&#x02013;18% sucrose/PBS gradient. For histological studies in dorsal skin and interscapular BAT (iBAT) of P0-P6.5 mice, tissues were fixed in 4% PFA/PBS and then embedded in paraffin. Cryo and paraffin embedding, sectioning, H&#x00026;E and Oil Red O staining were performed at UTSW Molecular Pathology Core. For Perilipin-1 and MAC-2 immunofluorescence in AT, sections were deparaffinized in xylene and rehydrated in a graded series of ethanol followed by dH<sub>2</sub>O. Antigen unmasking was carried out by heating slices in 10&#x000a0;mM sodium citrate buffer (pH 6.0) at 95&#x02013;99&#x000a0;&#x000b0;C for 10&#x000a0;min. Tissue sections were blocked and then incubated overnight at 4&#x000a0;&#x000b0;C with primary antibodies. After the washing steps, fluorochrome-conjugated secondary antibodies were incubated for 1&#x000a0;h at room temperature. For immunofluorescence detection in cultured cells, MEFs were seeded on glass coverslips and adipogenic differentiation was induced as described above. At the indicated days, differentiated MEFs were fixed in 4% PFA, washed with PBS and permeabilizated/blocked in 0.3% Triton X-100; 3% BSA/PBS. Primary and secondary antibody incubation steps were performed as described above. Finally, all stained slides and coverslips were mounted with ProLong<sup>&#x000ae;</sup> Gold Antifade Reagent with 4&#x02032;,6&#x02032;-diamidino-2-phenylindole (DAPI) (Molecular Probes). Images were captured with Leica SP5 Tandem Scanner Spectral 2-photon confocal microscope (Leica Microsystems, Inc., Buffalo Grove, IL) and processed with ImageJ (NIH, Bethesda, MD, US) and Bitplane Imaris software v. 7.3.1 (Andor Technology PLC, Belfast, N. Ireland). The following antibodies and dilutions were used: rabbit anti-Perilipin-1 (1:300, Cell Signalling), rabbit anti-Caveolin-1 (1:100, Cell Signalling), rabbit anti-PPAR&#x003b3; (1:100, Cell Signalling) and rat anti-MAC-2 (1:200, Cedarlane). Alexa Fluor<sup>&#x000ae;</sup> 488 or 594 goat anti-rabbit IgG (H&#x000a0;+&#x000a0;L) and Alexa Fluor<sup>&#x000ae;</sup> 488 goat anti-rat IgG (Molecular Probes) were diluted 1:300 in blocking buffer. F-actin was stained with rhodamine phalloidin (1:30 in PBS, Molecular Probes). For neutral lipid staining in MEFs, samples were incubated with 1&#x000a0;&#x003bc;g/ml BODIPY 493/503 (Molecular Probes).</p></sec><sec id="sec2.5"><label>2.5</label><title>TUNEL assay</title><p>Apoptotic cells were detected by the terminal deoxynucleotidyl-transferase-mediated deoxyuridine-triphosphate-biotin nick-end labeling (TUNEL) method using DeadEnd Fluorometric TUNEL System (Promega, Madison, WI) according the manufacturer's protocol. For TUNEL/Perilipin-1 double-labeled assay, paraffin sections of adipose tissue were first treated for TUNEL staining followed by immunofluorescent detection of Perilipin-1. Nuclei were counterstained with propidium iodide or DAPI as indicated. Stained samples were examined by confocal scanning laser microscopy.</p></sec><sec id="sec2.6"><label>2.6</label><title>Transmission electron microscopy</title><p>Dissected tissues from anterior subcutaneous regions and differentiated MEFs were fixed in 2% glutaraldehyde; 0.1&#x000a0;M cacodylate buffer and processed at the UTSW Electron Microscopy Core Facility. Sections were examined with a TEM Tecnai Spirit electron microscope and photographed with a Morada CCD camera.</p></sec><sec id="sec2.7"><label>2.7</label><title>Immunoblot analysis and antibodies</title><p>MEF protein extracts were prepared in RIPA buffer (50&#x000a0;mM Tris pH 8.0, 180&#x000a0;mM NaCl, 1% NP-40, 1% sodium deoxycholic acid, 0.1&#x000a0;mM EGTA and 0.1% sodium dodecyl sulfate (SDS)) supplemented with protease and phosphatase inhibitor cocktails (Roche) and 1&#x000a0;mM phenylmethylsulfonyl fluoride (PMSF). Proteins (50&#x000a0;&#x003bc;g) were denaturated in Laemmli's sample buffer (62.5&#x000a0;mM Tris, pH 6.8, 2% SDS, 25% glycerol, 0.01% bromophenol blue, and 5% &#x003b2;-mercaptoethanol), separated in a SDS-polyacrylamide gel and electrotransferred onto a nitrocellulose membrane. Membranes were blocked with 5% bovine serum albumin (BSA)/tris phosphate buffer 0.1% Tween 20 (TBS-T) and incubated overnight at 4&#x000a0;&#x000b0;C with primary antibodies diluted in 5% BSA/TBS-T solution. Rabbit antibodies against PPAR&#x003b3;, C/EBP&#x003b1;, C/EBP&#x003b2;, C/EBP&#x003b3;, &#x003b2;-actin, ATG12, Beclin, Akt (pan) and anti-rabbit IgG, HRP-linked antibodies were all purchased from Cell Signalling. Blots were visualized by chemiluminescence detection using Super Signal<sup>&#x000ae;</sup> West Pico Reagents (Pierce).</p></sec><sec id="sec2.8"><label>2.8</label><title>Real-time reverse transcription PCR</title><p>Total RNA was extracted from iBAT, posterior subcutaneous AT and MEFs using RNA STAT-60 reagent (TEL-TEST). 2&#x000a0;&#x003bc;g of total RNA were reverse transcribed with High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Real-time PCR was performed on ABI Prism<sup>&#x000ae;</sup> 7900 HT thermalcycler (Applied Biosystems) using SYBR<sup>&#x000ae;</sup> Green PCR Master Mix (Applied Biosystems) as reported <xref rid="bib5" ref-type="bibr">[5]</xref>. Individual mRNA levels were normalized to 36B4 and expressed as fold-change relative to non-differentiated <italic>Agpat2</italic><sup>+/+</sup> MEFs or wild type mice AT, with the &#x00394;&#x00394;Ct method. Primer sequences used for real time PCR are provided in <xref rid="appsec2" ref-type="sec">Supplementary Table&#x000a0;1</xref>.</p></sec><sec id="sec2.9"><label>2.9</label><title>Recombinant adenovirus</title><p>PPAR&#x003b3;2 encoding adenovirus was generated with ViraPower adenoviral expression system (Invitrogen). The PPAR&#x003b3;2 cDNA was amplified with Phusion high fidelity DNA polymerase (New England Biolabs) from a mouse liver cDNA library. PCR products were gel-purified and cloned into pENTR/D-TOPO vector (Invitrogen). The orientation and the sequence of the inserted cDNAs were confirmed by sequencing. Recombinant adenoviral vectors were generated by Clonase II mediated recombination between PPAR&#x003b3;2-pENTR/D-TOPO and pAd/CMV/V5-DEST vector (Invitrogen). Resulting recombinant plasmids were confirmed by sequencing. Infecting adenoviral particles were generated by transfecting 1&#x000a0;&#x003bc;g of PacI digested PPAR&#x003b3;2-pAD/CMV/V5-DEST in 293A cells using FuGENE 6 reagent (Roche Diagnostics). Adenoviral particles were purified in CsCl gradients and quantified by OD at 260&#x000a0;nm. 6&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup> adenoviral particles were used to transduce MEFs in 60&#x000a0;mm dishes.</p></sec><sec id="sec2.10"><label>2.10</label><title>Lipid extraction and phospholipid composition analysis</title><p>Total triglycerides from differentiated MEFs were extracted and measured using Triglyceride Colorimetric Assay Kit (Cayman Chemicals) according to the manufacturer's instructions. To extract total glycerophospholipids, differentiated MEFs were collected and snap-frozen immediately in liquid nitrogen. Next, samples were homogenized with 2&#x000a0;ml of ice-cold Tris&#x02013;HCl 20&#x000a0;mM containing protease inhibitors. Then, 0.8 the homogenized sample was vigorously mixed with CHCl<sub>3</sub> and 0.1&#x000a0;N HCl:CH<sub>3</sub>OH methanol in a 0.8:1:1 ratio. Next, an equal amount of CHCl<sub>3</sub> was added to the mix, manually shaken and centrifuged at 600&#x000a0;&#x000d7;&#x000a0;g for 10&#x000a0;min&#x000a0;at 4&#x000a0;&#x000b0;C. The lower phase was carefully removed and washed with a small volume of 1&#x000a0;M KCl. Extracted lipids were sent to Kansas Lipidomics Research Center (KLRC) for quantitation of phospholipid species. Automated electrospray ionization-tandem mass spectrometry approach was used, and data acquisition, analysis and identification were carried out as KLRC described previously <xref rid="bib13" ref-type="bibr">[13]</xref>, <xref rid="bib14" ref-type="bibr">[14]</xref>. The data are presented as mol% of the total lipids analyzed.</p></sec><sec id="sec2.11"><label>2.11</label><title>Imaging analysis</title><p>To quantify the number and size of adipocytes in histological sections of adipose tissue, adipocyte area was measured on hematoxylin and eosin stained slides using Adiposoft and ImageJ software as previously described <xref rid="bib15" ref-type="bibr">[15]</xref>. To determine the relative percentage of lipid-laden cells (cells containing LDs) after 6 days of differentiation, MEFs were grown on glass coverslips and differentiated. At day 6, cells were fixed and stained with BODIPY 493/503 to detect neutral lipids, rhodamine-phalloidin to detect cortical actin lining the inner surface of the plasma membrane in adipocytes <xref rid="bib16" ref-type="bibr">[16]</xref>, <xref rid="bib17" ref-type="bibr">[17]</xref>), and DAPI to stain cell nuclei. Samples were imaged using a confocal microscope. For cell counting, five non-overlapping fields were analyzed and quantified using Image J software (each field contained approximately 150 cells). The relative percentage of lipid-laden cells was determined as the ratio of BODIPY/cortical F-actin labeled cells to the total cell number per field. For time-course experiments, lipid-laden cells were monitored under an inverted microscope with phase contrast objectives at different days of differentiation. Images from the sample fields were captured at each time and then analyzed with Image J software. Quantitative image analysis of fluorescence intensity was performed with Image J software as previously described <xref rid="bib18" ref-type="bibr">[18]</xref>.</p></sec><sec id="sec2.12"><label>2.12</label><title>Statistical analysis</title><p>GraphPad Prism 5.00 (GraphPad, La Jolla, CA) was used for plotting and statistical analyses. Unpaired, two-sided Student's t-test was used to determine the statistical significance of the differences observed in two-group experiments. One-way ANOVA was used to compare three or more groups in some experiments. P-values of &#x0003c;0.05 were considered significant. (*), 0.01(**), and 0.001(***).</p></sec></sec><sec id="sec3"><label>3</label><title>Results</title><sec id="sec3.1"><label>3.1</label><title>Newborn <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice are born with subcutaneous white and brown adipose tissues, which are lost during the first week of life</title><p>As we previously reported, AGPAT2 deficient adult mice are completely devoid of all white adipose tissue (WAT) and brown adipose tissue (BAT) depots <xref rid="bib5" ref-type="bibr">[5]</xref>. Surprisingly, and in contrast, fetuses and newborn <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice have preserved adipose tissue, as indicated by Oil Red O and Perilipin-1 staining of thoracic transversal section of E18.5 and newborn mice (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>). Indeed, BAT was observed in the interscapular, subscapular, intercostal, and neck regions and had similar anatomic distribution and mass in both genotypes (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>A). Analysis of the dorsal area showed a well-defined layer of subcutaneous Oil-red O stained (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>B), Perilipin-1 expressing adipocytes (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>C) located throughout the hypodermis as well as the dermis of all examined <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice. The thin layer of anterior-subcutaneous WAT (scWAT) was nearly intact in the <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>B&#x02013;C). Interestingly, interscapular WAT, which normally covers the two lobes of interscapular BAT in adult mice <xref rid="bib19" ref-type="bibr">[19]</xref>, <xref rid="bib20" ref-type="bibr">[20]</xref>, was absent&#x000a0;in E18.5 embryos and newborn (P0.5) <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice but it was detectable soon after birth exclusively in <italic>Agpat2</italic><sup><italic>+/+</italic></sup> (data not shown). This suggests that this particular WAT depot is always absent in the <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice, possibly because most of its development is postnatal and coincides with times when adipose degeneration is already active in these animals. Interestingly, depots of posterior-subcutaneous WAT, which are located mainly in the dorsal-lumbar and lower ventral regions of the adult mice <xref rid="bib20" ref-type="bibr">[20]</xref>, <xref rid="bib21" ref-type="bibr">[21]</xref>, <xref rid="bib22" ref-type="bibr">[22]</xref>, <xref rid="bib23" ref-type="bibr">[23]</xref>, were observed in transverse sections of the inguinal region of both <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> newborn mice (<xref rid="appsec2" ref-type="sec">Supplementary Figure&#x000a0;1A&#x02013;B</xref>).</p><p>Histological analysis at postnatal times showed that subcutaneous adipocytes in wild type mice continuously increased their cell volume over the course of the first week (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>A, upper panels). In <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> newborn mice at day P0.5, subcutaneous adipocytes were smaller and their size did not increase during the following days (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>A, lower panels). Instead, the subcutaneous space of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice was filled with multilocular cells that lacked adipocyte morphology (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>A, lower panels).</p><p>In contrast to scWAT, abundant BAT was present in newborn <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice. Analysis of interscapular BAT (iBAT) showed normal multilocular brown adipocytes in the <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice at the time of birth (P0.5) (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B), indicating that brown adipocyte commitment and differentiation is normal in AGPAT2 deficient fetuses. Starting from P2.5, the iBAT of <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice showed aberrant lipid accumulation in brown adipocytes and progressive tissue deterioration, including a reduced number of multilocular adipocytes, abundant unilocular lipid laden cells, and inflammatory cell infiltration. At day P6.5, BAT was completely replaced by an amorphous basophilic material, cell debris, mononuclear cells and giant histiocytes surrounding large lipid drops, possibly reflecting coalesced material from dead adipocytes (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B).</p><p>Three-dimensional reconstruction of Perilipin-1 stained scWAT from newborn mice (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>C) and adipocyte size quantification confirmed that most adipocytes were smaller in the <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>D). In addition, adipocyte number was drastically reduced at P2.5 in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>E). Three-dimensional reconstruction of Perilipin-1 stained scWAT and iBAT sections from P4.5 mice supported that the AT in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice had abnormal adipocytes and disorganized architecture (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>F).</p><p>Gene expression analysis of adipocyte markers and adipogenic transcription factors was performed in AT at various times during the postnatal period. In the scWAT of wild type mice, mRNA levels of Leptin, Adiponectin, Perilipin-1, PPAR&#x003b3; and AGPAT2, progressively increased during the first week of life (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>G) as has been previously observed <xref rid="bib22" ref-type="bibr">[22]</xref>. In contrast, the mRNA level of these genes remained either undetectable (Leptin) or very low (Adiponectin, Perilipin-1, PPAR&#x003b3;) in <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> scWAT (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>G). In agreement with the morphological normality of BAT in newborn <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B), transcript levels of Adiponectin, UCP1, CIDEA and PPAR&#x003b3; were similar between <italic>Agpat2</italic><sup>+/+</sup> and <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice at day P0.5 (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>H). However, and matching the morphological deterioration of BAT in aging <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice, the expression levels of these genes progressively decreased after birth (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>H). Interestingly, AT degeneration coincides with increased lipid accumulation in the livers of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice (<xref rid="appsec2" ref-type="sec">Supplementary Figure&#x000a0;1C</xref>), suggesting that the development of the lipodystrophic phenotype triggers insulin resistance in these mice.</p><p>Transmission electron microscopy (TEM) analysis of adipocytes from anterior scWAT sections revealed a number of ultrastructural anomalies in white adipocytes of newborn <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice. Whereas <italic>Agpat2</italic><sup><italic>+/+</italic></sup> adipocytes were large, with one or two big sized LDs (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A), and had normally structured mitochondria (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C) and abundant caveolae in the plasma membrane (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C, red arrowheads); <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> adipocytes were smaller, had multiple LDs (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B), their mitochondria showed abnormal internal complexity (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>D), and they had a markedly decreased number of caveolae (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>D&#x02013;E). Furthermore, <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> adipocytes showed abundant autophagic structures (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>F&#x02013;I, encircled in dashed red lines; <xref rid="fig3" ref-type="fig">3J</xref>). To evaluate whether the lack of caveolae in <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> adipocytes is due to reduced levels of Caveolin-1, a major structural protein of caveolae <xref rid="bib24" ref-type="bibr">[24]</xref>, Caveolin-1 was inmunostained in the scWAT of these mice. Intriguingly, three-dimensional reconstruction of confocal images showed equivalent levels of Caveolin-1 in <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> adipocytes (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>K&#x02013;L). However, most <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> adipocytes showed abnormal distribution of Caveolin-1 (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>K), possibly indicating altered trafficking or mislocalization of this protein in structures other than caveolae.</p><p>Combined, these observations suggest that both BAT and subcutaneous WAT adipocyte precursor commitment and differentiation take place normally in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> fetuses and that postnatal lipodystrophic degeneration affects both lineages equally in these mice. Even though <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice are born with near normal BAT at the histological and molecular level the scWAT has distinct morphological abnormalities.</p></sec><sec id="sec3.2"><label>3.2</label><title>Lack of AGPAT2 triggers postnatal adipocyte death in mice</title><p>To evaluate the mechanism of postnatal AT degeneration in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice, cell death was assessed by TUNEL staining and TEM. TUNEL-positive cells were undetectable in AT of wild type mice at days P0.5 and P4.5 (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>A, left panels). In contrast, at day P0.5, TUNEL-positive cells were present in the scWAT of <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice and were very abundant in both scWAT and BAT at day P4.5 (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>A, right panels). Three-dimensional reconstruction and surface rendering of confocal data from TUNEL/Perilipin-1 double-labeled scWAT (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>B, upper panel) or BAT (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>B, lower panel) sections revealed that most of the TUNEL-positive nuclei belonged to adipocytes in the <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice. Moreover, pyknotic nuclei were abundant in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> BAT (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B, dashed area in high magnification panel).</p><p>TEM analysis revealed that the degeneration of the scWAT in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice was also characterized by abundant apoptotic bodies of varying size (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>C, red arrows), residual &#x0201c;free LDs&#x0201d; in the interstitial space (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>C, yellow arrows) and neighboring phagocyte (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>C, yellow arrowhead) surrounding the free lipid material extruded from dead adipocytes. Interestingly, &#x0201c;free LDs&#x0201d; have been previously described in models of obesity-associated adipocyte death, which is characterized by morphological features of necrosis, apoptosis, and pyroptosis <xref rid="bib25" ref-type="bibr">[25]</xref>, <xref rid="bib26" ref-type="bibr">[26]</xref>. The examination of degenerating BAT also showed large areas of terminal cell disintegration with fragments of intracellular components, including abundant &#x0201c;free lipid&#x0201d; material (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>C, areas outlined by red dashed lines) suggesting secondary necrosis <xref rid="bib27" ref-type="bibr">[27]</xref>.</p><p>Abundant non-adipocyte cells were detected in the AT of <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>, <xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>C). We speculated that they corresponded to inflammatory cells infiltrating the degenerating AT of <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice. To determine the identity of these cells, the macrophage cell-surface marker MAC-2 was assessed by immunofluorescence. At day P0.5, MAC-2 expressing cells were undetectable in the AT of both genotypes (data not shown); however, abundant MAC-2 positive macrophages were exclusively present in AT from <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice at day P4.5, remaining undetectable in the wild type mice at that time (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>D). Consistent with this observation, mRNA levels for NF&#x003ba;B, Caspase-1, TNF&#x003b1; and IL-6 were increasingly abundant in the iBAT of <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>E).</p><p>These observations indicate that massive adipocyte death precludes the postnatal expansion and maintenance of WAT and BAT in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> newborn mice and suggest that inflammatory infiltration plays a role in the lipodystrophic phenotype of these mice.</p></sec><sec id="sec3.3"><label>3.3</label><title>AGPAT2 deficient MEFs have impaired adipocyte differentiation <italic>in&#x000a0;vitro</italic></title><p>To further analyze the importance of AGPAT2 for adipocyte differentiation, we evaluated the capacity of post-confluent mouse embryonic fibroblasts (MEFs) to differentiate into adipocyte-like cells <italic>in&#x000a0;vitro</italic>.</p><p>After 6 days of adipogenic differentiation, nearly 50% of <italic>Agpat2</italic><sup><italic>+/+</italic></sup> MEFs accumulated neutral lipids as determined by BODIPY staining and cellularity analysis (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>A&#x02013;B). By contrast, only 28% of <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> MEFs differentiated to adipocyte-like cells (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>A&#x02013;B) and the total concentration of triglycerides was significantly lower in these cells (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>C). The mRNA levels of key transcriptional regulators, enzymes, lipid transporters, lipid droplet (LD) associated proteins, and adipokines were also lower in adipogenically differentiated <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> MEFs (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>D).</p><p>Perilipin-1 and Caveolin-1, both highly enriched proteins in mature adipocytes, were immunostained in MEFs after 6 days of differentiation to determine the phenotype of the lipid-laden cells. Abundant Perilipin-1 (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>E) and Caveolin-1 (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>F) were coating LDs and decorating the plasma membrane, respectively, in differentiated lipid-laden <italic>Agpat2</italic><sup><italic>+/+</italic></sup> MEFs. Interestingly, although lipid-laden cells were smaller in cultured <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs, Perilipin-1 properly coated LDs (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>E). By contrast, Caveolin-1 was irregularly distributed, with a higher proportion localized in intracellular structures, possibly the Golgi complex (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>F, white arrowheads). This abnormal distribution of Caveolin-1 was also present in subcutaneous adipocytes of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>K).</p><p>TEM analysis of differentiated MEFs revealed ultrastructural differences between genotypes (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>). Along with their characteristic large LDs, differentiated <italic>Agpat2</italic><sup><italic>+/+</italic></sup> MEFs showed abundant well-structured mitochondria (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>A). In contrast, differentiated lipid-laden <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs had fewer mitochondria and the internal structure of these organelles was altered (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>A&#x02013;B). Similar to subcutaneous adipocytes of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>F&#x02013;I), AGPAT2 deficient MEFs had significant accumulation of autophagic structures (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>A, C, yellow arrowheads; <xref rid="fig6" ref-type="fig">6D</xref>). Also as observed in mice adipocytes (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C&#x02013;D), caveolae were abundant in the plasma membrane of differentiated <italic>Agpat2</italic><sup><italic>+/+</italic></sup> MEFs but were virtually absent in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>E&#x02013;F). To further characterize autophagy in differentiating <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs, autophagy-related (ATG) proteins were assessed by immunoblotting. ATG12-ATG5 conjugate is essential for autophagosome formation <xref rid="bib28" ref-type="bibr">[28]</xref>, <xref rid="bib29" ref-type="bibr">[29]</xref> and has been shown to increase during the adipogenic differentiation in MEFs <xref rid="bib30" ref-type="bibr">[30]</xref>. Here, we observed that ATG12-ATG5 conjugates were progressively increased as differentiation progressed in MEFs of both genotypes, but were significantly higher in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs at all the time points (<xref rid="appsec2" ref-type="sec">Supplementary Figure&#x000a0;2A</xref>). In contrast, levels of Beclin, which is an important regulator of vesicle nucleation during the initial steps of autophagy <xref rid="bib28" ref-type="bibr">[28]</xref>, were similar between <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs during adipogenic differentiation (<xref rid="appsec2" ref-type="sec">Supplementary Figure&#x000a0;2B</xref>).</p><p>Taken together, our results support the idea that <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs are able to initiate the process of adipogenic differentiation; however, they undergo a wide variety of cellular abnormalities that finally block the terminal phase of adipogenesis.</p></sec><sec id="sec3.4"><label>3.4</label><title>PPAR&#x003b3; overexpression partially rescues adipogenesis in <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> MEFs</title><p>The nuclear receptor PPAR&#x003b3;, as well as the C/EBP family of transcription factors, are critical regulators of adipogenesis <xref rid="bib31" ref-type="bibr">[31]</xref>, <xref rid="bib32" ref-type="bibr">[32]</xref>. Therefore, we assessed the expression levels of C/EBPs and PPAR&#x003b3; during the adipogenic differentiation of MEFs. As expected, adipogenic induction resulted in early expression of C/EBP&#x003b2; and C/EBP&#x003b4;, followed by upregulation of C/EBP&#x003b1; and PPAR&#x003b3; mRNA and protein levels in <italic>Agpat2</italic><sup><italic>+/+</italic></sup> MEFs (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>A&#x02013;B). C/EBP&#x003b2;, -&#x003b4;, -&#x003b1;, and PPAR&#x003b3; were also increased after adipogenic induction of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs, but the expression level of these markers was significantly lower at all the time points (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>A&#x02013;B). In spite of these differences, differentiated lipid-laden <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> MEFs have similar intensity of PPAR&#x003b3; immunofluorescence signal than wild type differentiated lipid-laden MEFs (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>C).</p><p>To test if PPAR&#x003b3; overexpression could rescue the capacity of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs to undergo full adipogenesis <italic>in&#x000a0;vitro</italic>, post-confluent MEFs were infected with a PPAR&#x003b3;2 encoding adenovirus 24&#x000a0;h before adipogenic induction (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>D). As previously reported <xref rid="bib33" ref-type="bibr">[33]</xref>, <xref rid="bib34" ref-type="bibr">[34]</xref>, <xref rid="bib35" ref-type="bibr">[35]</xref>, <xref rid="bib36" ref-type="bibr">[36]</xref>, we observed that overexpression of PPAR&#x003b3;2 enhanced the adipogenic potential of <italic>Agpat2</italic><sup><italic>+/+</italic></sup> MEFs in comparison with <italic>Agpat2</italic><sup><italic>+/+</italic></sup> MEFs uninfected or infected with a LacZ encoding adenovirus (data not shown). In <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs, PPAR&#x003b3;2 overexpression significantly increased the proportion of adipocyte-like cells after 6 days of differentiation (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>E), as well as the total TG concentration (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>F) and mRNA levels of adipocyte markers (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>G) in comparison with <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs infected with a LacZ encoding adenovirus. Overexpression of PPAR&#x003b3;2 was unable to rescue the abnormal cellular morphology of differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>H). We noted that the proportion of lipid-laden <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> cells progressively declined during the course of the differentiation, in contrast with wild type cells that remained constant (<xref rid="appsec2" ref-type="sec">Supplementary Figure&#x000a0;2B</xref>). This anomaly was not corrected by PPAR&#x003b3;2 overexpression (<xref rid="appsec2" ref-type="sec">Supplementary Figure&#x000a0;2B</xref>), suggesting that PPAR&#x003b3; defects are not the main driving force for abnormal adipogenesis in AGPAT2 deficient adipocytes. To evaluate whether this decreasing number of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> lipid-laden cells was the result of increased cell death, TUNEL analysis was performed in adipogenically induced MEFs cultures. Similar to our findings in postnatal adipose tissue of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>A), a higher number of differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs was TUNEL-positive, in comparison with wild type MEFs (<xref rid="appsec2" ref-type="sec">Supplementary Figure&#x000a0;2C</xref>, left panels) and PPAR&#x003b3;2 overexpression was unable revert the cell death of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs (<xref rid="appsec2" ref-type="sec">Supplementary Figure&#x000a0;2C</xref>, right panels).</p></sec><sec id="sec3.5"><label>3.5</label><title>Accumulation of phosphatidic acid and altered phospholipid composition in differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs</title><p>An altered phospholipid composition may perturb membrane remodeling, intracellular signaling, autophagy, and LD expandibility during adipogenesis <xref rid="bib37" ref-type="bibr">[37]</xref>, <xref rid="bib38" ref-type="bibr">[38]</xref> and thus may be a determinant of death in AGPAT2 deficient adipocytes. Supporting this idea, it was previously reported that Caveolin-1 deficient adipocytes have abnormal phospholipid composition which is a determinant of small-sized LDs <xref rid="bib39" ref-type="bibr">[39]</xref>. Moreover, epidimal WAT and BAT depots from adipose-specific Seipin knockout mice have accumulation of several lipid species, including phospholipids, which is accompanied with cell stress and cell death of AT <xref rid="bib40" ref-type="bibr">[40]</xref>.</p><p>Since the conversion of LPA to PA by AGPATs is an intermediary step involved in glycerophospholipid biosynthesis pathway (<xref rid="fig8" ref-type="fig">Figure&#x000a0;8</xref>A) and AGPAT2 expression is strongly elevated during adipocyte differentiation <xref rid="bib11" ref-type="bibr">[11]</xref>, we aimed to determine whether the absence of AGPAT2 generates unbalanced levels of LPA, PA and potentially other phospholipids during adipogenesis. Therefore, we quantified the abundance of total LPA, PA and major phospholipids in differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs. Mass spectrometry analysis revealed no significant differences in the LPA content between differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> and <italic>Agpat2</italic><sup><italic>+/+</italic></sup> MEFs. In contrast, levels of PA were &#x0223c;3-fold higher in differentiated <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> MEFs in comparison with wild type MEFs (<xref rid="fig8" ref-type="fig">Figure&#x000a0;8</xref>B), indicating that alternative pathway(s) exist for the synthesis of PA in the absence of AGPAT2. Although the specific molecular identity of the fatty acid moieties composing PA were not revealed by our mass spectrometry analysis, differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs had significantly elevated levels of 32:1, 32:0 and 34:1&#x000a0;PA species (<xref rid="fig8" ref-type="fig">Figure&#x000a0;8</xref>C). In addition, increased levels of phosphatidylcholine (PC) and decreased levels of phosphatidylserine (PS), phosphatidylinositol (PI) and phosphatidylglycerol (PG), were detected in differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs (<xref rid="fig8" ref-type="fig">Figure&#x000a0;8</xref>D). Therefore, complex changes in the phospholipid composition may disrupt not only the production of lipid mediators but also the membrane properties, lipid droplet expansion, and adipocyte survival of AGPAT2 deficient adipocytes.</p></sec></sec><sec id="sec4"><label>4</label><title>Discussion</title><p>Here we report that, in contrast to adult <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice, late fetuses and newborn <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice have near normal scWAT and iBAT with similar distribution and mass as in the wild type littermates and that lipodystrophy results from massive adipocyte death during the first week of life. At the ultrastructural level, white adipocytes in newborn <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> were smaller and had a marked reduction of plasma membrane caveolae, abnormally structured mitochondria and irregular LDs. In addition, enhanced accumulation of autophagic structures observed in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> adipocytes suggests that alternative pathways might be responsible for the widespread adipocyte death observed in the days following birth.</p><p>Our <italic>in&#x000a0;vitro</italic> studies underscore the importance of AGPAT2 during adipogenesis. It is noteworthy that <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEF cells were able to differentiate into adipocyte-like cells but in a lower proportion than <italic>Agpat2</italic><sup><italic>+/+</italic></sup> MEFs. This difference was evident at early stages of adipogenesis and manifested by severely reduced abundance of C/EBPs and PPAR&#x003b3; at both the mRNA and protein levels. Nonetheless, immunofluorescence analysis suggested that the levels of nuclear PPAR&#x003b3; was equivalent between differentiated lipid-laden <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> and wild type MEFs. Treatment of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs with the PPAR&#x003b3; agonist, rosiglitazone, during adipogenic induction did not improve adipogenesis (data not shown); however, overexpression of PPAR&#x003b3;2 increased the proportion of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs with adipocyte-like phenotype after adipogenic induction, although it did not prevent the increased death of differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs. Importantly, <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> lipid-laden MEFs also exhibit other additional hallmarks of adipogenic differentiation, including neutral lipid accumulation, presence of Perilipin-1 coated LDs and the expression of downstream adipogenic marker proteins such aP2/FABP4 and ATGL (data not shown). Combined, these results suggest that adipogenic actions of AGPAT2 may operate upstream of PPAR&#x003b3; and that PPAR&#x003b3; deficiency is not a major determinant of the impaired adipogenesis of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs.</p><p>In spite of these findings, we observed several ultrastructural abnormalities in differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs, suggesting that these cells lack the ability to sustain the differentiation process to reach a fully mature adipocyte phenotype and eventually they die.</p><p>Interestingly, the small cellular size, the irregular localization of Caveolin-1 and the remarkable absence of caveolae in differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs suggest that the lipodystrophy associated with mutations in <italic>AGPAT2</italic>, <italic>CAV1</italic>, or <italic>PTRF</italic> genes <xref rid="bib41" ref-type="bibr">[41]</xref>, <xref rid="bib42" ref-type="bibr">[42]</xref>, <xref rid="bib43" ref-type="bibr">[43]</xref>, <xref rid="bib44" ref-type="bibr">[44]</xref> may be mechanistically connected. Indeed, recent studies have shown that: 1) caveolae protect adipocytes against lipotoxicity-induced autolysis <xref rid="bib45" ref-type="bibr">[45]</xref>; 2) changes in Caveolin-1 distribution are related with the disappearance of caveolae in the plasma membrane <xref rid="bib46" ref-type="bibr">[46]</xref>; 3) autophagosome formation is constitutively activated in Caveolin-1 deficient adipocytes and in differentiated <italic>Cav1</italic><sup>&#x02212;/&#x02212;</sup> MEFs <xref rid="bib47" ref-type="bibr">[47]</xref>; and 4) <italic>Cav1</italic><sup>&#x02212;/&#x02212;</sup> adipocytes have increased levels of reactive species oxygen (ROS) and mitochondrial dysfunction in association with widespread adipocyte death <xref rid="bib48" ref-type="bibr">[48]</xref>, <xref rid="bib49" ref-type="bibr">[49]</xref>.</p><p>Notably, excessive accumulation of autophagic structures was also present in differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs, in association with increased ATG12/ATG5 complex but not Beclin levels. It is possible that the extensive accumulation of autophagic structures observed in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> lipid-laden cells, as well as in <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> adipocytes <italic>in&#x000a0;vivo</italic>, result from an altered autophagic flux or failed elimination of autophagic debris in these cells. It is also possible that the intracellular dysregulation of lipid species in differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs plays a role on this phenomenon. Therefore, detailed studies on autophagy dynamics will be needed to determine the actual status of autophagic processes in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> adipocytes and its role in the lipodystrophy of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice <xref rid="bib50" ref-type="bibr">[50]</xref>.</p><p>We found an altered phospholipid composition in AGPAT2 deficient MEFs. At this point, we do not know whether the altered phospholipid levels are a consequence of abnormal lipid metabolism during adipogenesis of AGPAT2 deficient MEFs. Similarly, our studies do not allow us to conclude a causal role of phospholipid composition abnormalities on the adipogenic inability of <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> MEFs. Interestingly, increased levels of PA have been reported in other cellular models of adipogenic impairment, including OP9 and 3T3-L1 cells in which AGPAT2 <xref rid="bib11" ref-type="bibr">[11]</xref> and Seipin <xref rid="bib51" ref-type="bibr">[51]</xref> were knocked down, respectively. Indeed, mutations in the <italic>Bscl2/Seipin</italic> gene also cause CGL in humans <xref rid="bib52" ref-type="bibr">[52]</xref> and mice <xref rid="bib40" ref-type="bibr">[40]</xref>, <xref rid="bib53" ref-type="bibr">[53]</xref>, <xref rid="bib54" ref-type="bibr">[54]</xref>, and <italic>in&#x000a0;vitro</italic> studies with Seipin deficient cells have shown impaired adipogenesis <xref rid="bib53" ref-type="bibr">[53]</xref>, <xref rid="bib55" ref-type="bibr">[55]</xref>, altered lipid metabolism <xref rid="bib56" ref-type="bibr">[56]</xref>, high levels of PA and supersized LD <xref rid="bib57" ref-type="bibr">[57]</xref>, <xref rid="bib58" ref-type="bibr">[58]</xref>, <xref rid="bib59" ref-type="bibr">[59]</xref>. Additionally, epidimal WAT and BAT depots from adipose-specific Seipin knockout mice have increased levels of total PA, ER-stress, inflammation and cell death <xref rid="bib40" ref-type="bibr">[40]</xref>.</p><p>Interestingly, a recent study demonstrated that Seipin, AGPAT2, and Lipin-1 physically interact with each other forming a complex in the ER during adipogenesis <xref rid="bib60" ref-type="bibr">[60]</xref>. This interaction may regulate an efficient flux of PA to specific pathways during adipogenic differentiation and also may be important for adipocyte growth. Therefore, a tentative hypothesis is that the disruption of Seipin-AGPAT2-Lipin-1 complex by the absence of one of these proteins may dysregulate other intracellular processes in which PA is implicated, including signaling, membrane trafficking and remodeling and autophagy. In support of this hypothesis, it was recently reported that increased PA levels due to Lipin-1 deficiency have deleterious effects on mitochondrial function and also impairs the autophagy flux in muscle, leading to accumulation of autophagy-related structures <xref rid="bib61" ref-type="bibr">[61]</xref>.</p><p>Although the mechanisms responsible for the elevated PA levels in AGPAT2 deficient cells remain unknown, alternative metabolic pathways must be activated to allow the synthesis of PA in these cells. In addition to the AGPAT-dependent synthesis, PA can be generated by hydrolysis of phosphatidylcholine or cardiolipin by phospholipase D superfamily members <xref rid="bib62" ref-type="bibr">[62]</xref>, <xref rid="bib63" ref-type="bibr">[63]</xref>, <xref rid="bib64" ref-type="bibr">[64]</xref>. PA can also be generated by phosphorylation of diacylglycerol (DAG) through the action of DAG kinases (DAGK) <xref rid="bib65" ref-type="bibr">[65]</xref> or by the addition of a fatty acid side chain to LPA through the action of other-non AGPAT LPA acyl transferases <xref rid="bib66" ref-type="bibr">[66]</xref>, <xref rid="bib67" ref-type="bibr">[67]</xref>. A recent study did show the upregulation of Dagk and Pld in the livers of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice <xref rid="bib68" ref-type="bibr">[68]</xref>. Further studies will be required to biochemically dissect these pathways and to elucidate the mechanism of abnormal phospholipid composition in adipogenically differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs.</p><p>A limitation of our study is that we could not study the <italic>in&#x000a0;vivo</italic> lipid composition of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> adipocytes. This was due to our technical inability to dissect the very minute mass of scWAT in embryos and newborn mice. Ongoing strategies are aimed to generate mouse models to purify specific cell populations in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice. These will provide new tools to assess the role of specific lipid species in the ultrastructural anomalies dependent on AGPAT2 deficiency in adipocytes and for dissecting the specific mechanisms by which adipocyte cell death causes lipodystrophy in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice.</p><p>In summary, we show that <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice are born with AT, which undergoes a rapid degenerative process that leads to the total destruction of AT during the first week after birth. At the ultrastructural level, <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> adipose tissue has decreased caveolae, abnormally conformed mitochondria and LDs amid abundant autophagic structures. Adipocyte-like cells from differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs recapitulate the abnormal phenotype observed in scWAT of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> newborn mice and have an abnormal phospholipid composition.</p><p>Based on our <italic>in&#x000a0;vivo</italic> and <italic>in&#x000a0;vitro</italic> findings, we propose AGPAT2 deficient adipocytes have an impaired capacity to adapt to the massive lipid availability associated with postnatal feeding, leading to cellular stress, death and inflammatory destruction of adipose tissue.</p></sec><sec id="sec5"><title>Author contributions</title><p>V.A.C. and J.D.H designed and wrote the grant. K.M.C designed specific aims, experiments and procedures. K.M.C performed the experiments and data analysis under the guidance of V.A.C. and J.D.H., which also contributed with additional funding and research support. C.O.L performed TUNEL/Perilipin-1 double-staining in tissues. Further reagents, materials, analysis tools and advice were provided by C.O.L., P.J.T., A.G and A.A. The manuscript was written by K.M.C. and V.A.C. All authors critically read and contributed to the manuscript.</p></sec></body><back><ref-list><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>A.</given-names></name></person-group><article-title>Lipodystrophies: genetic and acquired body fat disorders</article-title><source>Journal of Clinical Endocrinology &#x00026; Metabolism</source><volume>96</volume><year>2011</year><fpage>3313</fpage><lpage>3325</lpage><pub-id pub-id-type="pmid">21865368</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Cortes</surname><given-names>V.A.</given-names></name><name><surname>Fernandez-Galilea</surname><given-names>M.</given-names></name></person-group><article-title>Lipodystrophies: adipose tissue disorders with severe metabolic implications</article-title><source>Journal of Physiology and Biochemistry</source><volume>71</volume><year>2015</year><fpage>471</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">25833179</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>A.K.</given-names></name><name><surname>Arioglu</surname><given-names>E.</given-names></name><name><surname>De Almeida</surname><given-names>S.</given-names></name><name><surname>Akkoc</surname><given-names>N.</given-names></name><name><surname>Taylor</surname><given-names>S.I.</given-names></name><name><surname>Bowcock</surname><given-names>A.M.</given-names></name></person-group><article-title>AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34</article-title><source>Nature Genetics</source><volume>31</volume><year>2002</year><fpage>21</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">11967537</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>A.</given-names></name><name><surname>Fleckenstein</surname><given-names>J.L.</given-names></name><name><surname>Peshock</surname><given-names>R.M.</given-names></name><name><surname>Grundy</surname><given-names>S.M.</given-names></name></person-group><article-title>Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy</article-title><source>Journal of Clinical Endocrinology &#x00026; Metabolism</source><volume>75</volume><year>1992</year><fpage>358</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">1639935</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Cortes</surname><given-names>V.A.</given-names></name><name><surname>Curtis</surname><given-names>D.E.</given-names></name><name><surname>Sukumaran</surname><given-names>S.</given-names></name><name><surname>Shao</surname><given-names>X.</given-names></name><name><surname>Parameswara</surname><given-names>V.</given-names></name><name><surname>Rashid</surname><given-names>S.</given-names></name></person-group><article-title>Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy</article-title><source>Cell Metabolism</source><volume>9</volume><year>2009</year><fpage>165</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">19187773</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Cortes</surname><given-names>V.A.</given-names></name><name><surname>Smalley</surname><given-names>S.V.</given-names></name><name><surname>Goldenberg</surname><given-names>D.</given-names></name><name><surname>Lagos</surname><given-names>C.F.</given-names></name><name><surname>Hodgson</surname><given-names>M.I.</given-names></name><name><surname>Santos</surname><given-names>J.L.</given-names></name></person-group><article-title>Divergent metabolic phenotype between two sisters with congenital generalized lipodystrophy due to double AGPAT2 homozygous mutations. A clinical, genetic and in silico study</article-title><source>PLoS One</source><volume>9</volume><year>2014</year></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>A.K.</given-names></name><name><surname>Garg</surname><given-names>A.</given-names></name></person-group><article-title>Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways</article-title><source>Trends in Endocrinology and Metabolism</source><volume>14</volume><year>2003</year><fpage>214</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">12826327</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Eberhardt</surname><given-names>C.</given-names></name><name><surname>Gray</surname><given-names>P.W.</given-names></name><name><surname>Tjoelker</surname><given-names>L.W.</given-names></name></person-group><article-title>Human lysophosphatidic acid acyltransferase. cDNA cloning, expression, and localization to chromosome 9q34.3</article-title><source>Journal of Biological Chemistry</source><volume>272</volume><year>1997</year><fpage>20299</fpage><lpage>20305</lpage><pub-id pub-id-type="pmid">9242711</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Hollenback</surname><given-names>D.</given-names></name><name><surname>Bonham</surname><given-names>L.</given-names></name><name><surname>Law</surname><given-names>L.</given-names></name><name><surname>Rossnagle</surname><given-names>E.</given-names></name><name><surname>Romero</surname><given-names>L.</given-names></name><name><surname>Carew</surname><given-names>H.</given-names></name></person-group><article-title>Substrate specificity of lysophosphatidic acid acyltransferase beta &#x02013; evidence from membrane and whole cell assays</article-title><source>Journal of Lipid Research</source><volume>47</volume><year>2006</year><fpage>593</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">16369050</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>A.K.</given-names></name><name><surname>Sukumaran</surname><given-names>S.</given-names></name><name><surname>Cortes</surname><given-names>V.A.</given-names></name><name><surname>Tunison</surname><given-names>K.</given-names></name><name><surname>Mizrachi</surname><given-names>D.</given-names></name><name><surname>Sankella</surname><given-names>S.</given-names></name></person-group><article-title>Human 1-acylglycerol-3-phosphate O-acyltransferase isoforms 1 and 2: biochemical characterization and inability to rescue hepatic steatosis in Agpat2(-/-) gene lipodystrophic mice</article-title><source>Journal of Biological Chemistry</source><volume>286</volume><year>2011</year><fpage>37676</fpage><lpage>37691</lpage><pub-id pub-id-type="pmid">21873652</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Gale</surname><given-names>S.E.</given-names></name><name><surname>Frolov</surname><given-names>A.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Bickel</surname><given-names>P.E.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Bowcock</surname><given-names>A.</given-names></name></person-group><article-title>A regulatory role for 1-acylglycerol-3-phosphate-O-acyltransferase 2 in adipocyte differentiation</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><year>2006</year><fpage>11082</fpage><lpage>11089</lpage><pub-id pub-id-type="pmid">16495223</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Subauste</surname><given-names>A.R.</given-names></name><name><surname>Das</surname><given-names>A.K.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Elliot</surname><given-names>B.</given-names></name><name><surname>Evans</surname><given-names>C.</given-names></name><name><surname>El Azzouny</surname><given-names>M.</given-names></name></person-group><article-title>Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations</article-title><source>Diabetes</source><volume>61</volume><year>2012</year><fpage>2922</fpage><lpage>2931</lpage><pub-id pub-id-type="pmid">22872237</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Devaiah</surname><given-names>S.P.</given-names></name><name><surname>Roth</surname><given-names>M.R.</given-names></name><name><surname>Baughman</surname><given-names>E.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Tamura</surname><given-names>P.</given-names></name><name><surname>Jeannotte</surname><given-names>R.</given-names></name></person-group><article-title>Quantitative profiling of polar glycerolipid species from organs of wild-type Arabidopsis and a phospholipase Dalpha1 knockout mutant</article-title><source>Phytochemistry</source><volume>67</volume><year>2006</year><fpage>1907</fpage><lpage>1924</lpage><pub-id pub-id-type="pmid">16843506</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Welti</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Sang</surname><given-names>Y.</given-names></name><name><surname>Biesiada</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>H.E.</given-names></name></person-group><article-title>Profiling membrane lipids in plant stress responses. Role of phospholipase D alpha in freezing-induced lipid changes in Arabidopsis</article-title><source>Journal of Biological Chemistry</source><volume>277</volume><year>2002</year><fpage>31994</fpage><lpage>32002</lpage><pub-id pub-id-type="pmid">12077151</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Galarraga</surname><given-names>M.</given-names></name><name><surname>Campion</surname><given-names>J.</given-names></name><name><surname>Munoz-Barrutia</surname><given-names>A.</given-names></name><name><surname>Boque</surname><given-names>N.</given-names></name><name><surname>Moreno</surname><given-names>H.</given-names></name><name><surname>Martinez</surname><given-names>J.A.</given-names></name></person-group><article-title>Adiposoft: automated software for the analysis of white adipose tissue cellularity in histological sections</article-title><source>Journal of Lipid Research</source><volume>53</volume><year>2012</year><fpage>2791</fpage><lpage>2796</lpage><pub-id pub-id-type="pmid">22993232</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Kanzaki</surname><given-names>M.</given-names></name><name><surname>Pessin</surname><given-names>J.E.</given-names></name></person-group><article-title>Insulin-stimulated GLUT4 translocation in adipocytes is dependent upon cortical actin remodeling</article-title><source>Journal of Biological Chemistry</source><volume>276</volume><year>2001</year><fpage>42436</fpage><lpage>42444</lpage><pub-id pub-id-type="pmid">11546823</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Kanzaki</surname><given-names>M.</given-names></name><name><surname>Pessin</surname><given-names>J.E.</given-names></name></person-group><article-title>Caveolin-associated filamentous actin (Cav-actin) defines a novel F-actin structure in adipocytes</article-title><source>Journal of Biological Chemistry</source><volume>277</volume><year>2002</year><fpage>25867</fpage><lpage>25869</lpage><pub-id pub-id-type="pmid">12039946</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>McCloy</surname><given-names>R.A.</given-names></name><name><surname>Rogers</surname><given-names>S.</given-names></name><name><surname>Caldon</surname><given-names>C.E.</given-names></name><name><surname>Lorca</surname><given-names>T.</given-names></name><name><surname>Castro</surname><given-names>A.</given-names></name><name><surname>Burgess</surname><given-names>A.</given-names></name></person-group><article-title>Partial inhibition of Cdk1 in G(2) phase overrides the SAC and decouples mitotic events</article-title><source>Cell Cycle</source><volume>13</volume><year>2014</year><fpage>1400</fpage><lpage>1412</lpage><pub-id pub-id-type="pmid">24626186</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>J.M.</given-names></name><name><surname>Larsson</surname><given-names>O.</given-names></name><name><surname>Cannon</surname><given-names>B.</given-names></name><name><surname>Nedergaard</surname><given-names>J.</given-names></name></person-group><article-title>A&#x000a0;stringent validation of mouse adipose tissue identity markers</article-title><source>American Journal of Physiology. Endocrinology and Metabolism</source><volume>308</volume><year>2015</year><fpage>E1085</fpage><lpage>E1105</lpage><pub-id pub-id-type="pmid">25898951</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Sanchez-Gurmaches</surname><given-names>J.</given-names></name><name><surname>Guertin</surname><given-names>D.A.</given-names></name></person-group><article-title>Adipocytes arise from multiple lineages that are heterogeneously and dynamically distributed</article-title><source>Nature Communications</source><volume>5</volume><year>2014</year></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Cinti</surname><given-names>S.</given-names></name></person-group><article-title>The adipose organ at a glance</article-title><source>Disease Models &#x00026; Mechanisms</source><volume>5</volume><year>2012</year><fpage>588</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">22915020</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Birsoy</surname><given-names>K.</given-names></name><name><surname>Berry</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Ceyhan</surname><given-names>O.</given-names></name><name><surname>Tavazoie</surname><given-names>S.</given-names></name><name><surname>Friedman</surname><given-names>J.M.</given-names></name></person-group><article-title>Analysis of gene networks in white adipose tissue development reveals a role for ETS2 in adipogenesis</article-title><source>Development</source><volume>138</volume><year>2011</year><fpage>4709</fpage><lpage>4719</lpage><pub-id pub-id-type="pmid">21989915</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Vitali</surname><given-names>A.</given-names></name><name><surname>Murano</surname><given-names>I.</given-names></name><name><surname>Zingaretti</surname><given-names>M.C.</given-names></name><name><surname>Frontini</surname><given-names>A.</given-names></name><name><surname>Ricquier</surname><given-names>D.</given-names></name><name><surname>Cinti</surname><given-names>S.</given-names></name></person-group><article-title>The adipose organ of obesity-prone C57BL/6J mice is composed of mixed white and brown adipocytes</article-title><source>Journal of Lipid Research</source><volume>53</volume><year>2012</year><fpage>619</fpage><lpage>629</lpage><pub-id pub-id-type="pmid">22271685</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Rothberg</surname><given-names>K.G.</given-names></name><name><surname>Heuser</surname><given-names>J.E.</given-names></name><name><surname>Donzell</surname><given-names>W.C.</given-names></name><name><surname>Ying</surname><given-names>Y.S.</given-names></name><name><surname>Glenney</surname><given-names>J.R.</given-names></name><name><surname>Anderson</surname><given-names>R.G.</given-names></name></person-group><article-title>Caveolin, a protein component of caveolae membrane coats</article-title><source>Cell</source><volume>68</volume><year>1992</year><fpage>673</fpage><lpage>682</lpage><pub-id pub-id-type="pmid">1739974</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Cinti</surname><given-names>S.</given-names></name><name><surname>Mitchell</surname><given-names>G.</given-names></name><name><surname>Barbatelli</surname><given-names>G.</given-names></name><name><surname>Murano</surname><given-names>I.</given-names></name><name><surname>Ceresi</surname><given-names>E.</given-names></name><name><surname>Faloia</surname><given-names>E.</given-names></name></person-group><article-title>Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans</article-title><source>Journal of Lipid Research</source><volume>46</volume><year>2005</year><fpage>2347</fpage><lpage>2355</lpage><pub-id pub-id-type="pmid">16150820</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Giordano</surname><given-names>A.</given-names></name><name><surname>Murano</surname><given-names>I.</given-names></name><name><surname>Mondini</surname><given-names>E.</given-names></name><name><surname>Perugini</surname><given-names>J.</given-names></name><name><surname>Smorlesi</surname><given-names>A.</given-names></name><name><surname>Severi</surname><given-names>I.</given-names></name></person-group><article-title>Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis</article-title><source>Journal of Lipid Research</source><volume>54</volume><year>2013</year><fpage>2423</fpage><lpage>2436</lpage><pub-id pub-id-type="pmid">23836106</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>M.T.</given-names></name><name><surname>do Vale</surname><given-names>A.</given-names></name><name><surname>dos Santos</surname><given-names>N.M.</given-names></name></person-group><article-title>Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications</article-title><source>Apoptosis</source><volume>13</volume><year>2008</year><fpage>463</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">18322800</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Maiuri</surname><given-names>M.C.</given-names></name><name><surname>Zalckvar</surname><given-names>E.</given-names></name><name><surname>Kimchi</surname><given-names>A.</given-names></name><name><surname>Kroemer</surname><given-names>G.</given-names></name></person-group><article-title>Self-eating and self-killing: crosstalk between autophagy and apoptosis</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>8</volume><year>2007</year><fpage>741</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">17717517</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Walczak</surname><given-names>M.</given-names></name><name><surname>Martens</surname><given-names>S.</given-names></name></person-group><article-title>Dissecting the role of the Atg12-Atg5-Atg16 complex during autophagosome formation</article-title><source>Autophagy</source><volume>9</volume><year>2013</year><fpage>424</fpage><lpage>425</lpage><pub-id pub-id-type="pmid">23321721</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Baerga</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>P.H.</given-names></name><name><surname>Goldman</surname><given-names>S.</given-names></name><name><surname>Jin</surname><given-names>S.</given-names></name></person-group><article-title>Targeted deletion of autophagy-related 5 (atg5) impairs adipogenesis in a cellular model and in mice</article-title><source>Autophagy</source><volume>5</volume><year>2009</year><fpage>1118</fpage><lpage>1130</lpage><pub-id pub-id-type="pmid">19844159</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Rosen</surname><given-names>E.D.</given-names></name><name><surname>Walkey</surname><given-names>C.J.</given-names></name><name><surname>Puigserver</surname><given-names>P.</given-names></name><name><surname>Spiegelman</surname><given-names>B.M.</given-names></name></person-group><article-title>Transcriptional regulation of adipogenesis</article-title><source>Genes &#x00026; Development</source><volume>14</volume><year>2000</year><fpage>1293</fpage><lpage>1307</lpage><pub-id pub-id-type="pmid">10837022</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Rosen</surname><given-names>E.D.</given-names></name><name><surname>MacDougald</surname><given-names>O.A.</given-names></name></person-group><article-title>Adipocyte differentiation from the inside out</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>7</volume><year>2006</year><fpage>885</fpage><lpage>896</lpage><pub-id pub-id-type="pmid">17139329</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>W.</given-names></name><name><surname>Takagi</surname><given-names>T.</given-names></name><name><surname>Kanesashi</surname><given-names>S.N.</given-names></name><name><surname>Kurahashi</surname><given-names>T.</given-names></name><name><surname>Nomura</surname><given-names>T.</given-names></name><name><surname>Harada</surname><given-names>J.</given-names></name></person-group><article-title>Schnurri-2 controls BMP-dependent adipogenesis via interaction with Smad proteins</article-title><source>Developmental Cell</source><volume>10</volume><year>2006</year><fpage>461</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">16580992</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Tontonoz</surname><given-names>P.</given-names></name><name><surname>Hu</surname><given-names>E.D.</given-names></name><name><surname>Spiegelman</surname><given-names>B.M.</given-names></name></person-group><article-title>Stimulation of adipogenesis in fibroblasts by Ppar-gamma-2, a lipid-activated transcription factor</article-title><source>Cell</source><volume>79</volume><year>1994</year><fpage>1147</fpage><lpage>1156</lpage><pub-id pub-id-type="pmid">8001151</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>D.L.</given-names></name><name><surname>Collingwood</surname><given-names>T.N.</given-names></name><name><surname>Rebar</surname><given-names>E.J.</given-names></name><name><surname>Wolffe</surname><given-names>A.P.</given-names></name><name><surname>Camp</surname><given-names>H.S.</given-names></name></person-group><article-title>PPAR gamma knockdown by engineered transcription factors: exogenous PPAR gamma 2 but not PPAR gamma 1 reactivates adipogenesis</article-title><source>Genes &#x00026; Development</source><volume>16</volume><year>2002</year><fpage>27</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">11782442</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Thuillier</surname><given-names>P.</given-names></name><name><surname>Baillie</surname><given-names>R.</given-names></name><name><surname>Sha</surname><given-names>X.M.</given-names></name><name><surname>Clarke</surname><given-names>S.D.</given-names></name></person-group><article-title>Cytosolic and nuclear distribution of PPAR gamma 2 in differentiating 3T3-L1 preadipocytes</article-title><source>Journal of Lipid Research</source><volume>39</volume><year>1998</year><fpage>2329</fpage><lpage>2338</lpage><pub-id pub-id-type="pmid">9831621</pub-id></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Eto</surname><given-names>M.</given-names></name><name><surname>Shindou</surname><given-names>H.</given-names></name><name><surname>Koeberle</surname><given-names>A.</given-names></name><name><surname>Harayama</surname><given-names>T.</given-names></name><name><surname>Yanagida</surname><given-names>K.</given-names></name><name><surname>Shimizu</surname><given-names>T.</given-names></name></person-group><article-title>Lysophosphatidylcholine acyltransferase 3 is the key enzyme for incorporating arachidonic acid into glycerophospholipids during adipocyte differentiation</article-title><source>International Journal of Molecular Sciences</source><volume>13</volume><year>2012</year><fpage>16267</fpage><lpage>16280</lpage><pub-id pub-id-type="pmid">23208369</pub-id></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Hishikawa</surname><given-names>D.</given-names></name><name><surname>Hashidate</surname><given-names>T.</given-names></name><name><surname>Shimizu</surname><given-names>T.</given-names></name><name><surname>Shindou</surname><given-names>H.</given-names></name></person-group><article-title>Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells</article-title><source>Journal of Lipid Research</source><volume>55</volume><year>2014</year><fpage>799</fpage><lpage>807</lpage><pub-id pub-id-type="pmid">24646950</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Blouin</surname><given-names>C.M.</given-names></name><name><surname>Le Lay</surname><given-names>S.</given-names></name><name><surname>Eberl</surname><given-names>A.</given-names></name><name><surname>Kofeler</surname><given-names>H.C.</given-names></name><name><surname>Guerrera</surname><given-names>I.C.</given-names></name><name><surname>Klein</surname><given-names>C.</given-names></name></person-group><article-title>Lipid droplet analysis in caveolin-deficient adipocytes: alterations in surface phospholipid composition and maturation defects</article-title><source>Journal of Lipid Research</source><volume>51</volume><year>2010</year><fpage>945</fpage><lpage>956</lpage><pub-id pub-id-type="pmid">19965594</pub-id></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Jiang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>R.C.</given-names></name><name><surname>Lam</surname><given-names>S.M.</given-names></name></person-group><article-title>Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy</article-title><source>Diabetes</source><volume>63</volume><year>2014</year><fpage>2320</fpage><lpage>2331</lpage><pub-id pub-id-type="pmid">24622797</pub-id></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sre41"><person-group person-group-type="author"><name><surname>Razani</surname><given-names>B.</given-names></name><name><surname>Combs</surname><given-names>T.P.</given-names></name><name><surname>Wang</surname><given-names>X.B.</given-names></name><name><surname>Frank</surname><given-names>P.G.</given-names></name><name><surname>Park</surname><given-names>D.S.</given-names></name><name><surname>Russell</surname><given-names>R.G.</given-names></name></person-group><article-title>Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities</article-title><source>Journal of Biological Chemistry</source><volume>277</volume><year>2002</year><fpage>8635</fpage><lpage>8647</lpage><pub-id pub-id-type="pmid">11739396</pub-id></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Brown</surname><given-names>D.</given-names></name><name><surname>McKee</surname><given-names>M.</given-names></name><name><surname>Lebrasseur</surname><given-names>N.K.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Albrecht</surname><given-names>K.H.</given-names></name></person-group><article-title>Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance</article-title><source>Cell Metabolism</source><volume>8</volume><year>2008</year><fpage>310</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">18840361</pub-id></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>Y.K.</given-names></name><name><surname>Matsuda</surname><given-names>C.</given-names></name><name><surname>Ogawa</surname><given-names>M.</given-names></name><name><surname>Goto</surname><given-names>K.</given-names></name><name><surname>Tominaga</surname><given-names>K.</given-names></name><name><surname>Mitsuhashi</surname><given-names>S.</given-names></name></person-group><article-title>Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy</article-title><source>Journal of Clinical Investigation</source><volume>119</volume><year>2009</year><fpage>2623</fpage><lpage>2633</lpage><pub-id pub-id-type="pmid">19726876</pub-id></element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C.A.</given-names></name><name><surname>Delepine</surname><given-names>M.</given-names></name><name><surname>Boutet</surname><given-names>E.</given-names></name><name><surname>El Mourabit</surname><given-names>H.</given-names></name><name><surname>Le Lay</surname><given-names>S.</given-names></name><name><surname>Meier</surname><given-names>M.</given-names></name></person-group><article-title>Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy</article-title><source>Journal of Clinical Endocrinology &#x00026; Metabolism</source><volume>93</volume><year>2008</year><fpage>1129</fpage><lpage>1134</lpage><pub-id pub-id-type="pmid">18211975</pub-id></element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Meshulam</surname><given-names>T.</given-names></name><name><surname>Breen</surname><given-names>M.R.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Parton</surname><given-names>R.G.</given-names></name><name><surname>Pilch</surname><given-names>P.F.</given-names></name></person-group><article-title>Caveolins/caveolae protect adipocytes from fatty acid-mediated lipotoxicity</article-title><source>Journal of Lipid Research</source><volume>52</volume><year>2011</year><fpage>1526</fpage><lpage>1532</lpage><pub-id pub-id-type="pmid">21652731</pub-id></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Briand</surname><given-names>N.</given-names></name><name><surname>Prado</surname><given-names>C.</given-names></name><name><surname>Mabilleau</surname><given-names>G.</given-names></name><name><surname>Lasnier</surname><given-names>F.</given-names></name><name><surname>Le Liepvre</surname><given-names>X.</given-names></name><name><surname>Covington</surname><given-names>J.D.</given-names></name></person-group><article-title>Caveolin-1 expression and cavin stability regulate caveolae dynamics in adipocyte lipid store fluctuation</article-title><source>Diabetes</source><volume>63</volume><year>2014</year><fpage>4032</fpage><lpage>4044</lpage><pub-id pub-id-type="pmid">24969108</pub-id></element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Le Lay</surname><given-names>S.</given-names></name><name><surname>Briand</surname><given-names>N.</given-names></name><name><surname>Blouin</surname><given-names>C.M.</given-names></name><name><surname>Chateau</surname><given-names>D.</given-names></name><name><surname>Prado</surname><given-names>C.</given-names></name><name><surname>Lasnier</surname><given-names>F.</given-names></name></person-group><article-title>The lipoatrophic caveolin-1 deficient mouse model reveals autophagy in mature adipocytes</article-title><source>Autophagy</source><volume>6</volume><year>2010</year><fpage>754</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">20574167</pub-id></element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Bosch</surname><given-names>M.</given-names></name><name><surname>Mari</surname><given-names>M.</given-names></name><name><surname>Herms</surname><given-names>A.</given-names></name><name><surname>Fernandez</surname><given-names>A.</given-names></name><name><surname>Fajardo</surname><given-names>A.</given-names></name><name><surname>Kassan</surname><given-names>A.</given-names></name></person-group><article-title>Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility</article-title><source>Current Biology</source><volume>21</volume><year>2011</year><fpage>681</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">21497090</pub-id></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Asterholm</surname><given-names>I.W.</given-names></name><name><surname>Mundy</surname><given-names>D.I.</given-names></name><name><surname>Weng</surname><given-names>J.</given-names></name><name><surname>Anderson</surname><given-names>R.G.</given-names></name><name><surname>Scherer</surname><given-names>P.E.</given-names></name></person-group><article-title>Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1</article-title><source>Cell Metabolism</source><volume>15</volume><year>2012</year><fpage>171</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">22326219</pub-id></element-citation></ref><ref id="bib50"><label>50</label><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>Klionsky</surname><given-names>D.J.</given-names></name><name><surname>Abdelmohsen</surname><given-names>K.</given-names></name><name><surname>Abe</surname><given-names>A.</given-names></name><name><surname>Abedin</surname><given-names>M.J.</given-names></name><name><surname>Abeliovich</surname><given-names>H.</given-names></name><name><surname>Acevedo Arozena</surname><given-names>A.</given-names></name></person-group><article-title>Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)</article-title><source>Autophagy</source><volume>12</volume><year>2016</year><fpage>1</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">26799652</pub-id></element-citation></ref><ref id="bib51"><label>51</label><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Sim</surname><given-names>M.F.</given-names></name><name><surname>Dennis</surname><given-names>R.J.</given-names></name><name><surname>Aubry</surname><given-names>E.M.</given-names></name><name><surname>Ramanathan</surname><given-names>N.</given-names></name><name><surname>Sembongi</surname><given-names>H.</given-names></name><name><surname>Saudek</surname><given-names>V.</given-names></name></person-group><article-title>The human lipodystrophy protein seipin is an ER membrane adaptor for the adipogenic PA phosphatase lipin 1</article-title><source>Molecular Metabolism</source><volume>2</volume><year>2012</year><fpage>38</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">24024128</pub-id></element-citation></ref><ref id="bib52"><label>52</label><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name><surname>Magre</surname><given-names>J.</given-names></name><name><surname>Delepine</surname><given-names>M.</given-names></name><name><surname>Khallouf</surname><given-names>E.</given-names></name><name><surname>Gedde-Dahl</surname><given-names>T.</given-names><suffix>Jr.</suffix></name><name><surname>Van Maldergem</surname><given-names>L.</given-names></name><name><surname>Sobel</surname><given-names>E.</given-names></name></person-group><article-title>Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13</article-title><source>Nature Genetics</source><volume>28</volume><year>2001</year><fpage>365</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">11479539</pub-id></element-citation></ref><ref id="bib53"><label>53</label><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Yechoor</surname><given-names>V.K.</given-names></name><name><surname>Chang</surname><given-names>B.H.</given-names></name><name><surname>Li</surname><given-names>M.V.</given-names></name><name><surname>March</surname><given-names>K.L.</given-names></name><name><surname>Chan</surname><given-names>L.</given-names></name></person-group><article-title>The human lipodystrophy gene product Berardinelli-Seip congenital lipodystrophy 2/seipin plays a key role in adipocyte differentiation</article-title><source>Endocrinology</source><volume>150</volume><year>2009</year><fpage>4552</fpage><lpage>4561</lpage><pub-id pub-id-type="pmid">19574402</pub-id></element-citation></ref><ref id="bib54"><label>54</label><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Deng</surname><given-names>J.</given-names></name></person-group><article-title>Seipin ablation in mice results in severe generalized lipodystrophy</article-title><source>Human Molecular Genetics</source><volume>20</volume><year>2011</year><fpage>3022</fpage><lpage>3030</lpage><pub-id pub-id-type="pmid">21551454</pub-id></element-citation></ref><ref id="bib55"><label>55</label><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Chang</surname><given-names>B.</given-names></name><name><surname>Saha</surname><given-names>P.</given-names></name><name><surname>Hartig</surname><given-names>S.M.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Reddy</surname><given-names>V.T.</given-names></name></person-group><article-title>Berardinelli-seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation</article-title><source>Molecular and Cellular Biology</source><volume>32</volume><year>2012</year><fpage>1099</fpage><lpage>1111</lpage><pub-id pub-id-type="pmid">22269949</pub-id></element-citation></ref><ref id="bib56"><label>56</label><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Fhaner</surname><given-names>C.J.</given-names></name><name><surname>Gross</surname><given-names>B.C.</given-names></name><name><surname>Lydic</surname><given-names>T.A.</given-names></name></person-group><article-title>Altered lipid metabolism in residual white adipose tissues of Bscl2 deficient mice</article-title><source>PLoS One</source><volume>8</volume><year>2013</year><fpage>e82526</fpage><pub-id pub-id-type="pmid">24358199</pub-id></element-citation></ref><ref id="bib57"><label>57</label><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>Szymanski</surname><given-names>K.M.</given-names></name><name><surname>Binns</surname><given-names>D.</given-names></name><name><surname>Bartz</surname><given-names>R.</given-names></name><name><surname>Grishin</surname><given-names>N.V.</given-names></name><name><surname>Li</surname><given-names>W.P.</given-names></name><name><surname>Agarwal</surname><given-names>A.K.</given-names></name></person-group><article-title>The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><volume>104</volume><year>2007</year><fpage>20890</fpage><lpage>20895</lpage><pub-id pub-id-type="pmid">18093937</pub-id></element-citation></ref><ref id="bib58"><label>58</label><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Fei</surname><given-names>W.</given-names></name><name><surname>Shui</surname><given-names>G.</given-names></name><name><surname>Gaeta</surname><given-names>B.</given-names></name><name><surname>Du</surname><given-names>X.</given-names></name><name><surname>Kuerschner</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name></person-group><article-title>Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast</article-title><source>Journal of Cell Biology</source><volume>180</volume><year>2008</year><fpage>473</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">18250201</pub-id></element-citation></ref><ref id="bib59"><label>59</label><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name><surname>Fei</surname><given-names>W.</given-names></name><name><surname>Shui</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Krahmer</surname><given-names>N.</given-names></name><name><surname>Ferguson</surname><given-names>C.</given-names></name><name><surname>Kapterian</surname><given-names>T.S.</given-names></name></person-group><article-title>A role for phosphatidic acid in the formation of &#x0201c;supersized&#x0201d; lipid droplets</article-title><source>PLOS Genetics</source><volume>7</volume><year>2011</year><fpage>e1002201</fpage><pub-id pub-id-type="pmid">21829381</pub-id></element-citation></ref><ref id="bib60"><label>60</label><element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name><surname>Talukder</surname><given-names>M.M.U.</given-names></name><name><surname>Sim</surname><given-names>M.F.M.</given-names></name><name><surname>O'Rahilly</surname><given-names>S.</given-names></name><name><surname>Edwardson</surname><given-names>J.M.</given-names></name><name><surname>Rochford</surname><given-names>J.J.</given-names></name></person-group><article-title>Seipin oligomers can interact directly with AGPAT2 and lipin 1, physically scaffolding critical regulators of adipogenesis</article-title><source>Molecular Metabolism</source><volume>4</volume><year>2015</year><fpage>199</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">25737955</pub-id></element-citation></ref><ref id="bib61"><label>61</label><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Verity</surname><given-names>M.A.</given-names></name><name><surname>Reue</surname><given-names>K.</given-names></name></person-group><article-title>Lipin-1 regulates autophagy clearance and intersects with statin drug effects in skeletal muscle</article-title><source>Cell Metabolism</source><volume>20</volume><year>2014</year><fpage>267</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">24930972</pub-id></element-citation></ref><ref id="bib62"><label>62</label><element-citation publication-type="journal" id="sref62"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Frohman</surname><given-names>M.A.</given-names></name></person-group><article-title>Lipid signaling on the mitochondrial surface</article-title><source>Biochimica et Biophysica Acta</source><volume>1791</volume><year>2009</year><fpage>839</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">19540356</pub-id></element-citation></ref><ref id="bib63"><label>63</label><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>D.A.</given-names></name><name><surname>Salloum</surname><given-names>D.</given-names></name><name><surname>Menon</surname><given-names>D.</given-names></name><name><surname>Frias</surname><given-names>M.A.</given-names></name></person-group><article-title>Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR)</article-title><source>Journal of Biological Chemistry</source><volume>289</volume><year>2014</year><fpage>22583</fpage><lpage>22588</lpage><pub-id pub-id-type="pmid">24990952</pub-id></element-citation></ref><ref id="bib64"><label>64</label><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>S.Y.</given-names></name><name><surname>Huang</surname><given-names>P.</given-names></name><name><surname>Jenkins</surname><given-names>G.M.</given-names></name><name><surname>Chan</surname><given-names>D.C.</given-names></name><name><surname>Schiller</surname><given-names>J.</given-names></name><name><surname>Frohman</surname><given-names>M.A.</given-names></name></person-group><article-title>A common lipid links Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis</article-title><source>Nature Cell Biology</source><volume>8</volume><year>2006</year><fpage>1255</fpage><lpage>1262</lpage><pub-id pub-id-type="pmid">17028579</pub-id></element-citation></ref><ref id="bib65"><label>65</label><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>J.</given-names></name><name><surname>Abramovici</surname><given-names>H.</given-names></name><name><surname>Gee</surname><given-names>S.H.</given-names></name><name><surname>Topham</surname><given-names>M.K.</given-names></name></person-group><article-title>Diacylglycerol kinases as sources of phosphatidic acid</article-title><source>Biochimica et Biophysica Acta</source><volume>1791</volume><year>2009</year><fpage>942</fpage><lpage>948</lpage><pub-id pub-id-type="pmid">19264149</pub-id></element-citation></ref><ref id="bib66"><label>66</label><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>A.</given-names></name><name><surname>Hayashi</surname><given-names>Y.</given-names></name><name><surname>Matsumoto</surname><given-names>N.</given-names></name><name><surname>Nemoto-Sasaki</surname><given-names>Y.</given-names></name><name><surname>Oka</surname><given-names>S.</given-names></name><name><surname>Tanikawa</surname><given-names>T.</given-names></name></person-group><article-title>Glycerophosphate/Acylglycerophosphate acyltransferases</article-title><source>Biology (Basel)</source><volume>3</volume><year>2014</year><fpage>801</fpage><lpage>830</lpage><pub-id pub-id-type="pmid">25415055</pub-id></element-citation></ref><ref id="bib67"><label>67</label><element-citation publication-type="journal" id="sref67"><person-group person-group-type="author"><name><surname>Shindou</surname><given-names>H.</given-names></name><name><surname>Hishikawa</surname><given-names>D.</given-names></name><name><surname>Harayama</surname><given-names>T.</given-names></name><name><surname>Yuki</surname><given-names>K.</given-names></name><name><surname>Shimizu</surname><given-names>T.</given-names></name></person-group><article-title>Recent progress on acyl CoA: lysophospholipid acyltransferase research</article-title><source>Journal of Lipid Research</source><issue>Suppl.&#x000a0;50</issue><year>2009</year><fpage>S46</fpage><lpage>S51</lpage><pub-id pub-id-type="pmid">18931347</pub-id></element-citation></ref><ref id="bib68"><label>68</label><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name><surname>Sankella</surname><given-names>S.</given-names></name><name><surname>Garg</surname><given-names>A.</given-names></name><name><surname>Horton</surname><given-names>J.D.</given-names></name><name><surname>Agarwal</surname><given-names>A.K.</given-names></name></person-group><article-title>Hepatic gluconeogenesis is enhanced by phosphatidic acid which remains uninhibited by insulin in lipodystrophic <italic>Agpat2</italic><sup>-/-</sup> mice</article-title><source>Journal of Biological Chemistry</source><volume>289</volume><year>2014</year><fpage>4762</fpage><lpage>4777</lpage><comment>[Epub 2014 Jan 14]. PMID: <ext-link ext-link-type="uri" xlink:href="pmid:24425876" id="intref0010a">24425876</ext-link></comment><pub-id pub-id-type="pmid">24425876</pub-id></element-citation></ref></ref-list><sec id="appsec1"><title>Conflict of interest</title><p>The authors declare no financial or commercial conflict of interest.</p></sec><sec id="appsec2" sec-type="supplementary-material"><label>Appendix A</label><title>Supplementary data</title><p>The following are the Supplementary data related to this article:<supplementary-material content-type="local-data" id="ec1"><media xlink:href="mmc1.xlsx"/></supplementary-material><fig id="undfig2" position="anchor"><label>Supplementary Figure&#x000a0;1</label><caption><p><bold>(A)</bold> Oil red O/hematoxylin stained transversal sections at the inguinal level of newborn <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice. Bilateral subcutaneous inguinal WAT depots (left and middle images) are located between the skin and muscle fascia just anterior to the lower segment of the hind limbs. Higher magnification of the inguinal WAT depots stained with Oil red O (right image). <bold>(B)</bold> Perilipin-1 immunofluorescence staining (green) of inguinal WAT. F-actin was detected with phalloidin/rhodamine (red), indicating skeletal muscle. Nuclei were stained with DAPI (blue). <bold>(C)</bold> Development of hepatic steatosis matches adipose tissue destruction in <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice. Histological analysis (hematoxylin-eosin staining) shows growing lipids build up in the liver of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice starting at P2.5. No differences between female and male <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice were detected.</p></caption><graphic xlink:href="figs1"/></fig><fig id="undfig3" position="anchor"><label>Supplementary Figure&#x000a0;2</label><caption><p><bold>(A)</bold> Immunoblot analysis of whole-cell protein extracts from <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs at different days of differentiation. 50&#x000a0;&#x003bc;g of proteins were loaded, total Akt was used as loading control. <bold>(B)</bold> At the indicated times, the number of lipid-laden cells were counted as previously described. Graph shows the percentage of lipid-laden cells. <bold>(C)</bold> TUNEL assay in 10 days differentiated MEFs.</p></caption><graphic xlink:href="figs2"/></fig></p></sec><ack id="ack0010"><title>Acknowledgments</title><p>The authors want to thank Dr. Philip Scherer for reviewing the manuscript and providing critical comments and suggestions, and to Dr. Ana Maria Cuervo for her advice on the analysis and interpretation of autophagy-related structures. We also want to thank Mr. John M. Shelton from UTSW for histological suggestions and discussions in processing tissue samples, Mrs. Judy Sanchez from UTSW for her invaluable technical support with the mouse colony and Katie Tunison from UTSW for technical assistance and copyediting in the manuscripts. V.A.C was funded by <funding-source id="gs1">Fondecyt</funding-source> Grant 1141134 (Chile). K.M.C. was supported by <funding-source id="gs2">CONICYT Doctoral Fellowship</funding-source> program grants 21090704, 24120971, 75120111 (Chile). J.D.H was funded by the <funding-source id="gs3">NIH</funding-source> (U.S.) grant P01 DK088761. A.G and A.K.A. were supported by <funding-source id="gs4">National Institutes of Health</funding-source> Grants DK54387 and the <funding-source id="gs5">Southwestern Medical Foundation</funding-source>. Phospholipid composition analysis was performed at the Kansas Lipidomics Research Center Analytical Laboratory, supported by <funding-source id="gs6">National Science Foundation</funding-source> grants EPS 0236913, MCB 0455318 and 0920663, and DBI 0521587, NIH P20RR16475, <funding-source id="gs7">Kansas State University</funding-source>, the <funding-source id="gs8">Kansas Technology Enterprise Corp.</funding-source>, and <funding-source id="gs9">K-IDeA Networks of Biomedical Research Excellence</funding-source>.</p></ack><fn-group><fn id="appsec3" fn-type="supplementary-material"><label>Appendix A</label><p>Supplementary data related to this article can be found online at <ext-link ext-link-type="doi" xlink:href="10.1016/j.molmet.2016.05.004" id="intref0010">http://dx.doi.org/10.1016/j.molmet.2016.05.004</ext-link>.</p></fn></fn-group></back><floats-group><fig id="fig1"><label>Figure&#x000a0;1</label><caption><p><bold>Late fetuses and newborn <italic>Agpat2</italic></bold><sup><bold><italic>&#x02212;/&#x02212;</italic></bold></sup><bold>mice have normal adipose tissue mass, anatomical distribution and Perilipin-1 expression</bold>. <bold>(A)</bold> Oil red O/hematoxylin stained transversal thoracic sections revealed normal distribution of adipose tissue in E18.5 fetuses and newborn <italic>Agpat2</italic><sup>+/+</sup> and <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> mice. <bold>(B)</bold> Higher magnification of the dorsal areas stained with Oil red O showed a thin layer of lipid-laden cells in the hypodermis corresponding to developing subcutaneous white adipose tissue (scWAT) in animals of both genotypes. scWAT is separated from the interscapular brown adipose tissue (iBAT) by the panniculus carnosus muscle (outlined by dashed line) <bold>(C)</bold> Perilipin-1 immunofluorescence staining (green) revealed that lipid-laden cells correspond to adipocytes expressing Perilipin-1. F-actin was detected with Phalloidin/rhodamine (red), indicating skeletal muscle. Nuclei were stained with DAPI (blue). Images are representative of 6 embryos or fetuses per genotype and age.</p></caption><graphic xlink:href="gr1"/></fig><fig id="fig2"><label>Figure&#x000a0;2</label><caption><p><bold>Postnatal adipose tissue development and growth are impaired in <italic>Agpat2</italic></bold><sup><bold><italic>&#x02212;/&#x02212;</italic></bold></sup><bold>mice</bold>. <bold>(A&#x02013;B)</bold> Paraffin-embedded sections of anterior scWAT and iBAT from <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice were obtained at different days of postnatal life and stained with Hematoxylin and Eosin. Slides were photographed at 40&#x000d7; magnification. Images are representative of N&#x000a0;&#x0003e;&#x000a0;6 per genotype and age <bold>(C, F)</bold> Three-dimension digital reconstruction of Perilipin-1 stained (green) adipose tissue depots from <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice at P0.5 (C) and P4.5 (F), DAPI was used to stain nuclei (blue). <bold>(D)</bold> Histogram shows adipocyte size distribution in scWAT of <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> newborn mice (P0.5). <bold>(E)</bold> Quantitative comparison of total number of adipocyte per field in scWAT of newborn and P4.5 <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice. Adipocyte number and size were analyzed using Adiposoft software. At least 1000 adipocytes and 5&#x02013;6 different areas per mouse (N&#x000a0;=&#x000a0;4) were analyzed. <bold>(G&#x02013;H)</bold> Adipose tissue mRNA markers were assessed by qPCR in scWAT and iBAT depots at different pre and postnatal time points. Graphs represent the relative abundance of each transcript normalized to 36B4 mRNA. The bars show the mean&#x000a0;&#x000b1;&#x000a0;standard deviation (SD) of N&#x000a0;=&#x000a0;6. ***p&#x000a0;&#x0003c;&#x000a0;0.001 compared to <italic>Agpat2</italic><sup>+/+</sup> mice at E18.5.</p></caption><graphic xlink:href="gr2"/></fig><fig id="fig3"><label>Figure&#x000a0;3</label><caption><p><bold>Transmission electron microscopy reveals ultrastructural abnormalities in scWAT from newborn <italic>Agpat2</italic></bold><sup><bold><italic>&#x02212;/&#x02212;</italic></bold></sup><bold>mice</bold>. <bold>(A&#x02013;D)</bold> Representatives images of scWAT of <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice. Caveolae are depicted by red arrowhead. <bold>(E)</bold> Quantification of caveolae normalized against membrane length. <bold>(F&#x02013;I)</bold> scWAT of <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice show small adipocytes with numerous lipid droplets (LD), abnormal mitochondria (m), autophagic structures (enclosed by dashed red lines for clarity), and absence of plasma membrane caveolae. <bold>(J)</bold> Representative quantification of autophagic structures per adipocyte on section. For image comparative analysis and quantification, 20 adipocytes per sample were analyzed with a total of N&#x000a0;=&#x000a0;3 samples per experimental group. <bold>(K)</bold> Representative confocal co-immunofluorescence of caveolin-1 (red) and CD31 (magenta) on scWAT of newborn mice. Asterisks indicate <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> adipocytes with plasma membrane-associated Caveolin-1. <bold>(L)</bold> Quantitation of caveolin-1 immunofluorescence signal in adipocytes.</p></caption><graphic xlink:href="gr3"/></fig><fig id="fig4"><label>Figure&#x000a0;4</label><caption><p><bold>The loss of adipose tissue in <italic>Agpat2</italic></bold><sup><bold><italic>&#x02212;/&#x02212;</italic></bold></sup><bold>mice is associated with massive cell death and adipose inflammation</bold>. <bold>(A)</bold> Paraffin-embedded sections of scWAT and iBAT from <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> littermates were assessed by TUNEL staining. <bold>(B)</bold> 3D slide reconstruction and surface rendering of confocal data from TUNEL/Perilipin-1 double-labeled scWAT and iBAT from P2.5 mice. Volume-rendering in yellow color highlights TUNEL and DAPI co-localization. <bold>(C)</bold> TEM of degenerating adipocytes in scWAT and iBAT from <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> mice at P4.5. scWAT: red arrows indicate apoptotic bodies, yellow arrows indicate free lipid material (free &#x0201c;LDs&#x0201d;), red arrowhead indicates a phagocytic cell, blood vessel is outlined by a red dashed line. iBAT: red dashed areas show trace of extensive cell disintegration and leakage of intracellular components including lipid material. <bold>(D)</bold> Paraffin-embedded sections of scWAT and iBAT from <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> littermates were stained with anti-MAC-2 and detected by immunofluorescence. <bold>(E)</bold> The mRNA level of genes involved in inflammatory response were assessed by qPCR at different postnatal time points in iBAT of Agpat2<sup>+/+</sup> and Agpat2<sup>&#x02212;/&#x02212;</sup> mice. Graphs show the relative abundance of each transcript normalized to 36B4 mRNA. The bars show the means&#x000a0;&#x000b1;&#x000a0;SD of N&#x000a0;=&#x000a0;8. *** denote significant difference (p&#x000a0;&#x0003c;&#x000a0;0.001) compared to <italic>Agpat2</italic><sup>+/+</sup> mice at E18.5.</p></caption><graphic xlink:href="gr4"/></fig><fig id="fig5"><label>Figure&#x000a0;5</label><caption><p><bold>Adipogenic differentiation of <italic>Agpat2</italic></bold><sup><bold>&#x02212;/&#x02212;</bold></sup><bold>MEFs results in significantly fewer neutral lipid-laden cells after 6 days of differentiation</bold>. <bold>(A)</bold> Representative images (N&#x000a0;&#x0003e;&#x000a0;10) from 6 days differentiated MEFs stained with the neutral lipid dye BODIPY and DAPI. <bold>(B)</bold> Graph shows the grade of adipogenic differentiation expressed as percentage of BODIPY stained cells. <bold>(C)</bold> Graph shows total cellular triglycerides quantified by an enzymatic-colorimetric method. <bold>(D)</bold> mRNA levels of adipogenic transcription factors and adipocyte related markers were quantified by qPCR. Gene expression was normalized to 36B4 mRNA levels and presented as fold-change relative to non-differentiated <italic>Agpat2</italic><sup><italic>+/+</italic></sup> MEFs. Data correspond to the means&#x000a0;&#x000b1;&#x000a0;SD of six independent experiments (N&#x000a0;&#x0003e;&#x000a0;10). ***p&#x000a0;&#x0003c;&#x000a0;0.001 and **p&#x000a0;&#x0003c;&#x000a0;0.01 denote statistically significant difference compared to differentiated <italic>Agpat2</italic><sup><italic>+/+</italic></sup> MEFs after 6 days of differentiation. <bold>(E)</bold> Three dimensional digital reconstruction of fluorescence stacks of differentiated <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs stained with BODIPY and anti-Perilipin-1 antibody. <bold>(F)</bold> Representative confocal images of Caveolin-1 (red) and lipid droplets (green) in MEFs after 6 days of adipogenic differentiation. Caveolin-1 preferentially marks the plasma membrane but also intracellular structures, possibly the Golgi complex (white arrowheads).</p></caption><graphic xlink:href="gr5"/></fig><fig id="fig6"><label>Figure&#x000a0;6</label><caption><p><bold>AGPAT2 deficiency is associated with ultrastructural abnormalities in differentiated MEFs</bold>. Transmission electron microscopy of differentiated <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs at day 6 post adipogenic induction. <bold>(A)</bold> Comparative images show lipid-laden cells from differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs (right panel) have aberrant mitochondria (m) and numerous autophagic structures (yellow arrowheads) in comparison with differentiated <italic>Agpat2</italic><sup><italic>+/+</italic></sup> MEFs (left panel). <bold>(B)</bold> Representative imaging of mitochondria from differentiated <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs. <bold>(C)</bold> Representative imaging of autophagic structures that were observed only in differentiated <italic>Agpat2</italic><sup>&#x02212;/&#x02212;</sup> MEFs. <bold>(D)</bold> Relative percentage of lipid-laden cells containing more than 20 autophagic compartments per whole cell. <bold>(E)</bold> Representative imaging of plasma membrane contrasting the differences in the density of caveolae (red arrowheads) in differentiated MEFs of both genotypes. <bold>(F)</bold> Quantification of plasma membrane-associated caveloae normalized against membrane area. For image analysis and quantification, 10 differentiated lipid-laden cells per independent sample were imaged in each experiment with a total of N&#x000a0;=&#x000a0;4 samples per experimental group).</p></caption><graphic xlink:href="gr6"/></fig><fig id="fig7"><label>Figure&#x000a0;7</label><caption><p><bold>Overexpression of PPAR&#x003b3;2 increases the proportion of lipid laden-cells and the gene expression profile but not the morphology of differentiated <italic>Agpat2</italic></bold><sup><bold><italic>&#x02212;/&#x02212;</italic></bold></sup><bold>MEFs</bold>. <bold>(A)</bold> qPCR quantification of C/EBPs and PPAR&#x003b3; mRNA levels at early and late stages of adipogenic differentiation. Data were normalized to 36B4 mRNA levels and expressed as relative fold changes to non-differentiated <italic>Agpat2</italic><sup><italic>+/+</italic></sup> MEFs at day 0. <bold>(B)</bold> Immunoblot analysis of whole-cell protein extracts from <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs at different days of differentiation. 50&#x000a0;&#x003bc;g of proteins were loaded, &#x003b2;-actin was used as loading control. <bold>(C)</bold> Confocal immunofluorescence analysis of PPAR&#x003b3; in <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs at two different stages of adipocyte differentiation. Graphs show the relative total immunofluorescence signal of nuclear PPAR&#x003b3; per cell. <bold>(D)</bold> Time-line showing the adipogenic differentiation protocol used on primary cultures of <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs previously infected with recombinant adenoviruses. <bold>(E)</bold> Adipogenic differentiation expressed as percentage of BODIPY stained cell after 6 days of differentiation. <bold>(F)</bold> Total cellular triglycerides quantified by an enzymatic-colorimetric method. <bold>(G)</bold> mRNA levels of adipogenic transcription factors and adipocyte related markers were quantified by qPCR. Gene expression was normalized to 36B4 mRNA levels and presented as fold-change relative to non-differentiated <italic>Agpat2</italic><sup><italic>+/+</italic></sup> MEFs. <bold>(H)</bold> Three dimensional digital reconstruction of fluorescence stacks of differentiated <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs immunostained with anti-Perilipin-1 antibody (pink). Neutral lipids were stained with BODIPY (green). All bar graphs show mean&#x000a0;&#x000b1;&#x000a0;SD of three independent experiments (N&#x000a0;&#x0003e;&#x000a0;6). *** (p&#x000a0;&#x0003c;&#x000a0;0.001), **(p&#x000a0;&#x0003c;&#x000a0;0.01) and *(p&#x000a0;&#x0003c;&#x000a0;0.05) denote significant difference compared to <italic>Agpat2</italic><sup>+/+</sup> MEFs.</p></caption><graphic xlink:href="gr7"/></fig><fig id="fig8"><label>Figure&#x000a0;8</label><caption><p><bold>Phospholipid quantification in differentiated <italic>Agpat2</italic></bold><sup><bold>+/+</bold></sup><bold>and <italic>Agpat2</italic></bold><sup><bold>&#x02212;/&#x02212;</bold></sup><bold>MEFs</bold>. <bold>(A)</bold> Pathways for PA and phospholipid synthesis in mammals. <bold>(B&#x02013;C)</bold> Electron spray ionization-mass spectrometric analysis of phospholipids in differentiated <italic>Agpat2</italic><sup><italic>+/+</italic></sup> and <italic>Agpat2</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> MEFs. AGPAT: 1-acyl-sn-glycerol-3-phosphate acyltransferase; CL: cardiolipin; DAG: diacylglycerol; LPA: lysophosphatidic acid; PA: phosphatidic acid; PC: phosphatidylcholine; PE: phosphatidylethanolamine; PG: phosphatidylglycerol; PI: phosphatidylinositol; PS: phosphatidylserine; TAG: triacylglycerol. All bar graphs show mean&#x000a0;&#x000b1;&#x000a0;SD of three independent experiments (N&#x000a0;&#x0003e;&#x000a0;6). ***p&#x000a0;&#x0003c;&#x000a0;0.001, **p&#x000a0;&#x0003c;&#x000a0;0.01 and *p&#x000a0;&#x0003c;&#x000a0;0.05 denote significant difference compared to differentiated <italic>Agpat2</italic><sup>+/+</sup> MEFs.</p></caption><graphic xlink:href="gr8"/></fig></floats-group></article>